Anterior Spinal Artery Syndrome

Complex MONDO:0006650 Pathograph 17 Show in embeddings browser Arterial disorder

Anterior spinal artery syndrome is an acute ischemic spinal cord syndrome caused by infarction or hypoperfusion in the anterior spinal artery territory, which supplies the ventral two-thirds of the cord. Injury to the anterior horns, corticospinal tracts, spinothalamic tracts, and lateral horns produces acute motor weakness or paralysis, dissociated loss of pain and temperature sensation with relative dorsal-column sparing, and autonomic dysfunction. The syndrome is a territory-defined manifestation of spinal cord ischemia rather than a single etiologic disease.

Ask OpenScientist

Ask a research question about Anterior Spinal Artery Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

7
Pathophys.
6
Phenotypes
2
Gaps
17
Pathograph
4
Medical Actions
2
Differentials
10
References
2
Deep Research
?

Discussions and Knowledge Gaps

2
Which patients with hyperacute anterior spinal artery syndrome benefit from thrombolysis, spinal perfusion rescue, or other reperfusion strategies, and within what time window?
KNOWLEDGE GAP OPEN asas_acute_reperfusion_strategy
Attached to
treatments#Cerebrospinal fluid drainage with blood-pressure augmentation in selected acute cases treatments#Intravenous thrombolysis in carefully selected hyperacute occlusive ASAS
Acute care is extrapolated from cerebral stroke, aortic-surgery prevention, and uncontrolled spinal cord infarction case reports. Etiologic heterogeneity is crucial: thrombolysis could be hazardous in aortic dissection or spinal hemorrhage, while CSF drainage has its own procedural risks. The record therefore presents these as selected, low-certainty strategies rather than universal treatment recommendations.
Proposed experiments
Prospective multicenter hyperacute ASAS treatment registry
exp_asas_multicenter_acute_registry
Enroll patients using standardized time-to-nadir, MRI/DWI, vascular etiology, contraindication, ASIA, treatment-timing, safety, and long-term functional-outcome fields so causal-adjusted comparisons of reperfusion strategies become possible despite disease rarity.
Show evidence (2 references)
PMID:26386968 SUPPORT Human Clinical
"There is a lack of controlled clinical trials on acute treatment strategies in ASAS."
This directly supports the unresolved acute-treatment evidence gap.
PMID:39119546 SUPPORT Human Clinical
"Although there are no specific guidelines regarding treatment, the administration of rt-PA might be an effective therapy for acute ischemic stroke, preventing permanent spinal dysfunction."
This review explicitly notes the absence of specific guidelines while describing rt-PA as a possibility.
Which secondary ischemia-reperfusion and cell-death pathways demonstrated in animal spinal cord models are active, measurable, and therapeutically important in human anterior spinal artery syndrome?
HUMAN MODEL MISMATCH OPEN asas_preclinical_secondary_injury_translation
Attached to
pathophysiology#Hypoxic-ischemic spinal cord tissue injury
Animal aortic-occlusion models consistently demonstrate gray-matter-predominant injury and are used to study oxidative, inflammatory, apoptotic, pyroptotic, and ferroptotic mechanisms. Human ASAS evidence is dominated by clinical phenotype and imaging, so those molecular pathways are not promoted to established human causal nodes without translational confirmation.
Proposed experiments
Human ASAS longitudinal imaging-biomarker study
exp_asas_human_injury_biomarkers
Collect acute and serial spinal DWI/perfusion imaging, CSF and blood injury/inflammation markers, treatment timing, and ASIA outcomes to test whether candidate secondary-injury pathways track tissue evolution and functional recovery in humans.
Show evidence (1 reference)
DOI:10.1093/jnen/nlab084 SUPPORT Model Organism
"Preclinical models have been developed to simulate the clinical paradigm to better understand the neuropathophysiology and develop therapeutic treatment."
The systematic review explicitly identifies the mechanistic evidence base as preclinical modeling.
⚙

Pathophysiology

7
Anterior spinal artery territory perfusion failure
Occlusion or nonocclusive hypoperfusion in the anterior spinal artery or a supplying anterior medullary artery reduces delivery of oxygen and glucose to the ventral spinal cord. This is the common hemodynamic event that defines the ischemic form of anterior cord syndrome.
response to ischemia GO:0002931 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased response to ischemia (GO:0002931). GO:0002931 is a biological process from the Gene Ontology. ↑ INCREASED
anterior spinal artery UBERON:0005431 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in anterior spinal artery (UBERON:0005431). UBERON:0005431 is an anatomical location from the Uberon multi-species anatomy ontology. spinal cord UBERON:0002240 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in spinal cord (UBERON:0002240). UBERON:0002240 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Hypoxic-ischemic spinal cord tissue injury Inadequate anterior-territory perfusion directly produces hypoxic-ischemic stress in spinal cord tissue.
Acute back or neck pain Acute axial pain often accompanies onset, but its precise generator can vary with the vascular lesion, vertebral/disc context, and affected cord level; the graph therefore does not assert a single direct pain mechanism.
Rapid nadir of severe neurologic deficits Sustained perfusion failure causes rapidly evolving tissue injury and severe neurologic deficit, commonly reaching nadir within hours.
Show evidence (2 references)
PMID:37456462 SUPPORT Human Clinical
"Anterior cord syndrome (ACS) occurs as a result of ischemia in the territory of the anterior spinal artery (ASA)."
This directly anchors the syndrome to ischemia in the anterior spinal artery territory.
PMID:22962400 SUPPORT Human Clinical
"Anterior spinal artery syndrome (ASAS) is often a devastating spinal stroke occurring when the anterior spinal artery or one of its supplying anterior medullary arteries are occluded."
This clinical report supports occlusion of the artery or a supplying medullary artery as an ASAS mechanism.
Hypoxic-ischemic spinal cord tissue injury
Sustained perfusion failure initiates a hypoxic-ischemic injury cascade in neurons and supporting tissue. Human data establish the territory and clinical infarction; finer claims about oxidative stress, inflammatory cell death, or reperfusion injury remain derived mainly from animal models and are not presented here as proven human ASAS mechanisms.
neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology.
response to hypoxia GO:0001666 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased response to hypoxia (GO:0001666). GO:0001666 is a biological process from the Gene Ontology. ↑ INCREASED response to ischemia GO:0002931 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased response to ischemia (GO:0002931). GO:0002931 is a biological process from the Gene Ontology. ↑ INCREASED
spinal cord UBERON:0002240 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in spinal cord (UBERON:0002240). UBERON:0002240 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Anterior gray matter and long-tract infarction Persistent hypoxic-ischemic injury causes tissue infarction, with marked vulnerability of anterior gray matter and variable white-matter tract involvement.
Show evidence (1 reference)
DOI:10.1093/jnen/nlab084 SUPPORT Model Organism
"Spinal cord ischemic injury and paralysis are devastating complications after open surgical repair of thoracoabdominal aortic aneurysms."
A systematic review of preclinical aortic cross-clamping models supports ischemic cord injury while clearly limiting the evidence source to animal models.
Anterior gray matter and long-tract infarction
Infarction in the ventral two-thirds of the spinal cord involves anterior horn gray matter and descending motor, anterolateral sensory, and autonomic pathways. The exact extent varies with lesion level and completeness.
motor neuron CL:0000100 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves motor neuron (CL:0000100). CL:0000100 is a cell type from the Cell Ontology.
spinal cord UBERON:0002240 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in spinal cord (UBERON:0002240). UBERON:0002240 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Corticospinal tract and anterior horn motor-pathway injury Anterior-territory infarction directly injures motor neurons and descending corticospinal pathways.
Spinothalamic tract injury with relative dorsal-column sparing Anterior-territory infarction directly injures anterolateral spinothalamic pathways while commonly sparing posterior columns.
Lateral horn autonomic-pathway injury Anterior-territory infarction directly injures lateral horn autonomic pathways.
Show evidence (2 references)
PMID:37456462 SUPPORT Human Clinical
"the underlying neural structures responsible for these symptoms include the corticospinal tracts and anterior horns, anterolateral spinothalamic tracts, and lateral horns, respectively."
This directly identifies the structures underlying the motor, sensory, and autonomic syndrome.
PMID:30093205 SUPPORT Human Clinical
"MRI findings in anterior spinal artery infarcts included pencillike hyperintensities on T2 sagittal (n = 16, 100%) and "owl eye" appearance on T2 axial (n = 6, 37.5%) images."
The anterior-cord and bilateral anterior-horn imaging patterns support the territory-specific injury distribution.
Corticospinal tract and anterior horn motor-pathway injury
Anterior horn motor-neuron injury produces segmental lower-motor-neuron weakness, while corticospinal tract injury produces weakness below the lesion and can later yield hyperreflexia and spasticity.
motor neuron CL:0000100 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves motor neuron (CL:0000100). CL:0000100 is a cell type from the Cell Ontology.
spinal cord UBERON:0002240 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in spinal cord (UBERON:0002240). UBERON:0002240 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Paraplegia or paraparesis Bilateral injury to anterior horn and corticospinal motor pathways causes lower-extremity weakness or paralysis.
Delayed spasticity and instability Surviving patients with incomplete corticospinal injury may develop delayed upper-motor-neuron spasticity and postural instability.
Show evidence (1 reference)
PMID:37456462 SUPPORT Human Clinical
"The typical presentation of an ASA stroke is paraparesis or paraplegia"
This directly supports the core motor consequence of anterior-territory injury.
Spinothalamic tract injury with relative dorsal-column sparing
Injury to the anterolateral spinothalamic pathways impairs pain and temperature sensation below the lesion. Posterior-column position and vibration sensation can remain relatively preserved, producing the classic dissociated sensory pattern; incomplete and atypical patterns occur.
spinal cord UBERON:0002240 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in spinal cord (UBERON:0002240). UBERON:0002240 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Dissociated loss of pain and temperature sensation Spinothalamic tract injury directly reduces pain and temperature sensation below the lesion.
Show evidence (1 reference)
PMID:30093205 SUPPORT Human Clinical
"Clinical presentation included dissociative anesthesia, weakness of limbs, back or neck pain, and autonomic symptoms"
The anterior-territory case series supports dissociated sensory loss as a clinical presentation.
Lateral horn autonomic-pathway injury
Ischemic injury to spinal autonomic pathways disrupts bladder and bowel control. The exact autonomic phenotype varies with level and lesion extent.
spinal cord UBERON:0002240 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in spinal cord (UBERON:0002240). UBERON:0002240 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Urinary incontinence Lateral horn and descending autonomic pathway injury can directly impair bladder continence.
Show evidence (1 reference)
PMID:37456462 SUPPORT Human Clinical
"fecal or urinary incontinence"
This directly supports bowel or bladder autonomic dysfunction in ASAS.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Anterior Spinal Artery Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

6
Musculoskeletal 1
Delayed spasticity and instability HP:0001257 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Delayed spasticity, annotated with Spasticity (HP:0001257), qualified as temporality chronic. HP:0001257 is a phenotype from the Human Phenotype Ontology.
Temporal: CHRONIC
Show evidence (1 reference)
PMID:37456462 SUPPORT Human Clinical
"We report a case of incomplete or partial ACS presenting with delayed-onset spasticity and instability several months following EVAR, who was subsequently treated with intrathecal baclofen."
This supports the possibility of delayed spasticity after incomplete ASAS but not its population frequency.
Nervous System 1
Dissociated loss of pain and temperature sensation Impaired pain sensation HP:0007328 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dissociated loss of pain and temperature sensation, annotated with Impaired pain sensation (HP:0007328), qualified as temporality acute. HP:0007328 is a phenotype from the Human Phenotype Ontology.
Temporal: ACUTE
Show evidence (1 reference)
PMID:37456462 SUPPORT Human Clinical
"bilateral loss of pain and temperature sensation"
This directly supports the hallmark pain-temperature deficit.
Constitutional 2
Urinary incontinence HP:0000020 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Urinary incontinence (HP:0000020), qualified as temporality acute. HP:0000020 is a phenotype from the Human Phenotype Ontology.
Temporal: ACUTE
Show evidence (1 reference)
PMID:37456462 SUPPORT Human Clinical
"fecal or urinary incontinence"
This directly supports urinary or fecal incontinence as an autonomic manifestation.
Acute back or neck pain Back pain HP:0003418 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Acute back or neck pain, annotated with Back pain (HP:0003418), qualified as temporality acute. HP:0003418 is a phenotype from the Human Phenotype Ontology.
Temporal: ACUTE
Show evidence (1 reference)
PMID:30093205 SUPPORT Human Clinical
"Clinical presentation included dissociative anesthesia, weakness of limbs, back or neck pain, and autonomic symptoms"
The anterior-spinal-artery infarct series directly supports acute back or neck pain at presentation.
Other 2
Paraplegia or paraparesis Paraplegia/paraparesis HP:0010551 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Paraplegia/paraparesis (HP:0010551), qualified as temporality acute. HP:0010551 is a phenotype from the Human Phenotype Ontology.
Temporal: ACUTE
Show evidence (1 reference)
PMID:37456462 SUPPORT Human Clinical
"The typical presentation of an ASA stroke is paraparesis or paraplegia"
This directly supports the typical bilateral lower-extremity motor deficit.
Rapid nadir of severe neurologic deficits Rapid neurologic deterioration HP:0007307 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Rapid neurologic deterioration (HP:0007307), qualified as temporality acute. HP:0007307 is a phenotype from the Human Phenotype Ontology.
Temporal: ACUTE
Show evidence (1 reference)
DOI:10.3390/jcm14041293 SUPPORT Human Clinical
"The strongest predictor of SCI diagnosis is a clinical variable, i.e., a time to nadir of severe deficits < 12 h."
This directly supports the hyperacute severe-deficit trajectory.
💊

Medical Actions

4
Multimodal spinal cord ischemia prevention during high-risk aortic repair
Action: supportive careNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is supportive care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. Ontology label: Supportive Care NCIT:C15747
In patients undergoing descending thoracic or thoracoabdominal aortic repair, institutional prevention bundles may preserve collateral flow, stage extensive repairs, augment spinal cord perfusion, selectively drain cerebrospinal fluid, and maintain distal perfusion. This is prevention in a specific iatrogenic setting, not treatment for every spontaneous ASAS case.
Mechanism Target:
INHIBITS Aortic, arterial, or procedure-related spinal arterial supply compromise — The bundle reduces procedural collateral loss and low spinal cord perfusion pressure.
Show evidence (1 reference)
PMID:34740806 SUPPORT Human Clinical
"We found that a multimodal approach, including a bundled institutional protocol, staging of multiple repairs, preservation of the collateral blood flow network, augmented spinal cord perfusion, selective cerebrospinal fluid drainage, and distal aortic perfusion during open TAA repairs, appears..."
The systematic review directly links multimodal prevention to the upstream procedural supply-compromise mechanism.
Show evidence (1 reference)
PMID:34740806 SUPPORT Human Clinical
"We found that a multimodal approach, including a bundled institutional protocol, staging of multiple repairs, preservation of the collateral blood flow network, augmented spinal cord perfusion, selective cerebrospinal fluid drainage, and distal aortic perfusion during open TAA repairs, appears..."
This supports a bundled prevention strategy specifically for aortic-repair-associated ischemia.
Cerebrospinal fluid drainage with blood-pressure augmentation in selected acute cases
Action: supportive careNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is supportive care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. Ontology label: Supportive Care NCIT:C15747
Lowering intrathecal pressure while augmenting mean arterial pressure can increase spinal cord perfusion pressure in selected acute spinal cord infarcts, especially after aortic or embolization procedures. Evidence for established ASAS is limited to small uncontrolled series and must be balanced against drain-related hemorrhage, infection, and procedural risk.
Mechanism Target:
RESTORES Anterior spinal artery territory perfusion failure — CSF drainage plus MAP augmentation increases the pressure gradient driving spinal cord perfusion.
Show evidence (1 reference)
PMID:30294499 SUPPORT Human Clinical
"Lumbar cerebrospinal fluid drainage (CSFD) with blood pressure augmentation is utilized in the thoracic/thoracoabdominal aortic repair and thoracic endovascular aortic repair (TEVAR) populations to increase spinal perfusion pressure."
The three-case report states the hemodynamic mechanism but does not provide controlled ASAS-specific efficacy evidence.
Show evidence (1 reference)
PMID:30294499 SUPPORT Human Clinical
"There was significant improvement in the motor examination (e.g., ASIA impairment scale grade B or C) to grade D utilizing both blood pressure augmentation and CSFD."
Three uncontrolled acute spinal cord infarction cases improved after the combined intervention; this is low-certainty evidence.
Intravenous thrombolysis in carefully selected hyperacute occlusive ASAS
Action: Thrombolytic TherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Thrombolytic Therapy (NCIT:C15338). NCIT:C15338 is a clinical intervention from the NCI Thesaurus. NCIT:C15338
Intravenous thrombolysis has been reported within the cerebral-stroke time window after exclusion of aortic dissection, spinal hemorrhage, and other contraindications. It remains a candidate, not an established standard, because evidence consists of case reports and no controlled ASAS trials.
Mechanism Target:
RESTORES Anterior spinal artery territory perfusion failure — In an occlusive mechanism, thrombolysis is intended to restore arterial perfusion before irreversible infarction.
Show evidence (1 reference)
PMID:22962400 SUPPORT Human Clinical
"We believe thrombolysis should be considered in the acute phase of this condition, and present a case with ASAS who experienced partial recovery after treatment given 4.5 h after symptom onset."
This is a single case and author recommendation, so it supports only candidate use rather than efficacy.
Show evidence (2 references)
PMID:26386968 SUPPORT Human Clinical
"There is a lack of controlled clinical trials on acute treatment strategies in ASAS."
This directly establishes the evidence limitation around acute thrombolysis.
PMID:26386968 SUPPORT Human Clinical
"Systemic thrombolysis seems to be justifiable in patients with ASAS after the rule-out of aortal dissection and spinal bleeding."
The case report frames conditional candidate use after critical exclusions, not a guideline-level recommendation.
Neurorehabilitation and symptom-directed spasticity management
Action: RehabilitationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Rehabilitation (NCIT:C15315). NCIT:C15315 is a clinical intervention from the NCI Thesaurus. NCIT:C15315
Rehabilitation addresses residual motor, mobility, autonomic, and daily living limitations. Baclofen or other symptom-directed measures may be used for delayed spasticity in selected survivors, but the cited ASAS evidence is case-level and does not establish comparative effectiveness.
Mechanism Target:
MODULATES Delayed spasticity and instability — Rehabilitation and antispasticity management target chronic motor consequences rather than reversing established infarction.
Show evidence (1 reference)
PMID:37456462 SUPPORT Human Clinical
"We report a case of incomplete or partial ACS presenting with delayed-onset spasticity and instability several months following EVAR, who was subsequently treated with intrathecal baclofen."
This links intrathecal baclofen to delayed spasticity in one incomplete-ASAS case.
Show evidence (1 reference)
PMID:37456462 SUPPORT Human Clinical
"We report a case of incomplete or partial ACS presenting with delayed-onset spasticity and instability several months following EVAR, who was subsequently treated with intrathecal baclofen."
The case supports symptom-directed spasticity treatment but not a general rehabilitation protocol.
🔬

Diagnosis

1
Acute noncompressive myelopathy evaluated with spinal MRI and DWI
Diagnosis integrates a hyperacute myelopathy, an anterior-territory motor, sensory, and autonomic pattern, and MRI exclusion of cord compression. Compatible T2 and diffusion findings strengthen the diagnosis, but early MRI can be incomplete or nondiagnostic and no single supportive sign is pathognomonic.
magnetic resonance imaging procedure NCIT:C16809 NCI Thesaurus (NCIT)
Show evidence (2 references)
DOI:10.3390/jcm14041293 SUPPORT Human Clinical
"the lack of cord compression on Magnetic Resonance Imaging (MRI) is the only mandatory feature for diagnosis."
This supports MRI exclusion of compression as the mandatory imaging criterion in the proposed diagnostic framework.
PMID:39119546 SUPPORT Human Clinical
"Magnetic resonance imaging with diffusion- weighted contrast is a main tool with which to confirm SCI and rule out a broad spectrum of possible alternative diagnoses."
This supports MRI with diffusion weighting as the main confirmatory and exclusionary imaging approach.
🩻

Imaging Findings

3
Longitudinal pencil-like anterior cord T2 hyperintensity
Sagittal T2-weighted MRI can show a longitudinal pencil-like hyperintensity in the anterior cord. This is a supportive territory pattern rather than a finding unique to ASAS; no sufficiently specific NCIT/HP term is available, so the finding remains preferred-term-only.
Mri Diagnostic
Longitudinal pencil-like anterior spinal cord T2 hyperintensity spinal cord UBERON:0002240 Uberon multi-species anatomy ontology (UBERON)
Show evidence (1 reference)
PMID:30093205 SUPPORT Human Clinical
"MRI findings in anterior spinal artery infarcts included pencillike hyperintensities on T2 sagittal (n = 16, 100%)"
All 16 anterior-territory infarcts in this series showed the sagittal pencil-like T2 pattern.
Bilateral anterior horn owl-eye T2 hyperintensity
Axial T2-weighted MRI can show paired anterior-horn hyperintensities (the owl-eye or snake-eye appearance). It is supportive of anterior gray-matter ischemia but is neither universal nor pathognomonic; the appearance has no dedicated validated NCIT/HP binding here.
Mri Diagnostic Bilateral
Bilateral anterior horn owl-eye T2 hyperintensity spinal cord UBERON:0002240 Uberon multi-species anatomy ontology (UBERON)
Show evidence (1 reference)
PMID:30093205 SUPPORT Human Clinical
""owl eye" appearance on T2 axial (n = 6, 37.5%) images."
The sign occurred in 6 of 16 anterior-territory infarcts, supporting utility without claiming universality.
Diffusion restriction in the infarcted spinal cord
Restricted diffusion on DWI supports acute spinal cord infarction when technically adequate imaging is obtained, but sensitivity depends on acquisition timing and technique.
Mri Diagnostic
Spinal cord diffusion restriction spinal cord UBERON:0002240 Uberon multi-species anatomy ontology (UBERON)
Show evidence (2 references)
PMID:30093205 SUPPORT Human Clinical
"Diffusion restriction was noted in 8 cases and enhancement was noted in 2 cases."
This series directly documents diffusion restriction in anterior-territory infarcts without treating it as universal.
DOI:10.3390/jcm14041293 SUPPORT Human Clinical
"Some MRI features are supportive of the diagnosis, particularly when the anterior spinal artery territory is involved and diffusion-weighted imaging (DWI) is used."
The review identifies anterior-territory DWI findings as supportive rather than mandatory.
📈

Progression

2
Hyperacute ischemic presentation
Duration: Minutes to hours
Severe neurologic deficits usually reach their nadir rapidly. A slower or fluctuating course does not exclude infarction, but should broaden the differential diagnosis.
Show evidence (1 reference)
DOI:10.3390/jcm14041293 SUPPORT Human Clinical
"The strongest predictor of SCI diagnosis is a clinical variable, i.e., a time to nadir of severe deficits < 12 h."
The review identifies a severe-deficit nadir within 12 hours as the strongest diagnostic predictor.
Variable neurologic recovery with frequent residual disability
Duration: Months to years
Recovery is heterogeneous. Initial and nadir neurologic severity are the strongest prognostic indicators; anatomical level, etiology, age, and rehabilitation needs also shape outcome.
Show evidence (1 reference)
PMID:26154150 SUPPORT Human Clinical
"A literature review of 11 patient series of nontraumatic SCI found that prognosis is primarily determined by the severity of motor or sensory involvement, in particular, initial and nadir ASIA A/B scores which strongly correlate with poor outcome."
This review of clinical series supports severity at presentation and nadir as the dominant prognostic determinant.
🌍

Epidemiology

1
Rare and probably underrecognized spinal cord stroke syndrome
Population incidence specific to anterior spinal artery syndrome is not established. Arterial spinal cord infarction is rare and probably underdiagnosed, while anterior/centromedullary territory involvement is the most common vascular pattern in clinical series.
Show evidence (2 references)
DOI:10.3390/jcm14041293 SUPPORT Human Clinical
"Spinal cord infarction (SCI) of arterial origin is a rare vascular event, and its incidence is probably underestimated."
This human-focused review supports rarity and underrecognition without asserting an unsupported population rate.
PMID:25398656 SUPPORT Human Clinical
"Infarcts occurred in 38.2% at the cervical and thoracic level, respectively, and 49% of patients suffered from centromedullar syndrome caused by anterior spinal artery ischemia."
A 55-patient series identifies anterior-spinal-artery centromedullary syndrome as the largest territory-defined subgroup.
⚖️

Clinical Burden

High
The syndrome can abruptly cause paraplegia or tetraplegia, sensory loss, sphincter dysfunction, long-term wheelchair dependence, and death. Burden varies with lesion level and severity at nadir, but substantial permanent disability is common in published spinal cord infarction cohorts.
Show evidence (1 reference)
PMID:11641795 SUPPORT Human Clinical
"Acute spinal cord ischemia syndrome has a severe prognosis with permanent and disabling sequelae."
A clinical outcome series directly supports high disease burden and persistent disability.
🔀

Differential Diagnoses

2

Conditions with similar clinical presentations that must be differentiated from Anterior Spinal Artery Syndrome:

Compressive myelopathy
Overlapping Features Epidural, vertebral, disc, hemorrhagic, or neoplastic compression can cause an acute anterior cord phenotype. Demonstrated cord compression shifts the diagnosis away from arterial spinal cord infarction and may require urgent cause-directed intervention.
Distinguishing Features
  • Structural compression of the cord on MRI rather than a noncompressive vascular-territory lesion.
  • A mechanically explanatory lesion at the neurologic level.
Show evidence (1 reference)
DOI:10.3390/jcm14041293 SUPPORT Human Clinical
"the lack of cord compression on Magnetic Resonance Imaging (MRI) is the only mandatory feature for diagnosis."
The absence of compression is the mandatory diagnostic separator for spinal cord infarction in the cited framework.
Inflammatory acute or subacute myelopathy
Overlapping Features Inflammatory myelitis can mimic acute spinal cord infarction. A severe deficit reaching nadir within hours and a compatible anterior-territory DWI pattern favor infarction, while slower evolution or inflammatory evidence should broaden the work-up; atypical infarcts still occur.
Distinguishing Features
  • Severe neurologic nadir within 12 hours favors infarction over many inflammatory myelopathies.
  • Anterior-territory diffusion restriction supports infarction but is not universal.
  • Lack of cord compression is required for either noncompressive diagnostic pathway.
Show evidence (2 references)
DOI:10.3390/jcm14041293 SUPPORT Human Clinical
"Furthermore, many cases may be misdiagnosed as other forms of acute and subacute myelopathies."
The review explicitly identifies diagnostic confusion with other acute and subacute myelopathies.
DOI:10.3390/jcm14041293 SUPPORT Human Clinical
"The strongest predictor of SCI diagnosis is a clinical variable, i.e., a time to nadir of severe deficits < 12 h."
Rapid nadir provides a positive clinical discriminator while not excluding atypical cases.
{ }

Source YAML

click to show 
name: Anterior Spinal Artery Syndrome
creation_date: "2026-05-05T01:33:38Z"
description: >-
  Anterior spinal artery syndrome is an acute ischemic spinal cord syndrome
  caused by infarction or hypoperfusion in the anterior spinal artery
  territory, which supplies the ventral two-thirds of the cord. Injury to the
  anterior horns, corticospinal tracts, spinothalamic tracts, and lateral horns
  produces acute motor weakness or paralysis, dissociated loss of pain and
  temperature sensation with relative dorsal-column sparing, and autonomic
  dysfunction. The syndrome is a territory-defined manifestation of spinal
  cord ischemia rather than a single etiologic disease.
category: Complex
disease_term:
  preferred_term: anterior spinal artery syndrome
  term:
    id: MONDO:0006650
    label: anterior spinal artery syndrome
parents:
- Arterial disorder
synonyms:
- Anterior spinal cord infarction syndrome
- Ischemic anterior cord syndrome
- ASA syndrome

epidemiology:
- name: Rare and probably underrecognized spinal cord stroke syndrome
  description: >-
    Population incidence specific to anterior spinal artery syndrome is not
    established. Arterial spinal cord infarction is rare and probably
    underdiagnosed, while anterior/centromedullary territory involvement is the
    most common vascular pattern in clinical series.
  evidence:
  - reference: DOI:10.3390/jcm14041293
    reference_title: "Spinal Cord Infarction: Clinical and Neuroradiological Clues of a Rare Stroke Subtype"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Spinal cord infarction (SCI) of arterial origin is a rare vascular event,
      and its incidence is probably underestimated.
    explanation: This human-focused review supports rarity and underrecognition without asserting an unsupported population rate.
  - reference: PMID:25398656
    reference_title: "Spinal cord ischemia: aetiology, clinical syndromes and imaging features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Infarcts occurred in 38.2% at the cervical and thoracic level,
      respectively, and 49% of patients suffered from centromedullar syndrome
      caused by anterior spinal artery ischemia.
    explanation: A 55-patient series identifies anterior-spinal-artery centromedullary syndrome as the largest territory-defined subgroup.

clinical_burden:
  burden_level: HIGH
  rationale: >-
    The syndrome can abruptly cause paraplegia or tetraplegia, sensory loss,
    sphincter dysfunction, long-term wheelchair dependence, and death. Burden
    varies with lesion level and severity at nadir, but substantial permanent
    disability is common in published spinal cord infarction cohorts.
  evidence:
  - reference: PMID:11641795
    reference_title: "Spinal cord infarction: prognosis and recovery in a series of 36 patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Acute spinal cord ischemia syndrome has a severe prognosis with permanent
      and disabling sequelae.
    explanation: A clinical outcome series directly supports high disease burden and persistent disability.
progression:
- phase: Hyperacute ischemic presentation
  duration: Minutes to hours
  notes: >-
    Severe neurologic deficits usually reach their nadir rapidly. A slower or
    fluctuating course does not exclude infarction, but should broaden the
    differential diagnosis.
  evidence:
  - reference: DOI:10.3390/jcm14041293
    reference_title: "Spinal Cord Infarction: Clinical and Neuroradiological Clues of a Rare Stroke Subtype"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The strongest predictor of SCI diagnosis is a clinical variable, i.e., a
      time to nadir of severe deficits < 12 h.
    explanation: The review identifies a severe-deficit nadir within 12 hours as the strongest diagnostic predictor.
- phase: Variable neurologic recovery with frequent residual disability
  duration: Months to years
  notes: >-
    Recovery is heterogeneous. Initial and nadir neurologic severity are the
    strongest prognostic indicators; anatomical level, etiology, age, and
    rehabilitation needs also shape outcome.
  evidence:
  - reference: PMID:26154150
    reference_title: Nontraumatic spinal cord ischaemic syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A literature review of 11 patient series of nontraumatic SCI found that
      prognosis is primarily determined by the severity of motor or sensory
      involvement, in particular, initial and nadir ASIA A/B scores which
      strongly correlate with poor outcome.
    explanation: This review of clinical series supports severity at presentation and nadir as the dominant prognostic determinant.

pathophysiology:
- name: Aortic, arterial, or procedure-related spinal arterial supply compromise
  description: >-
    Aortic or vertebral atherosclerosis and dissection, embolic arterial
    occlusion, systemic hypoperfusion, and interruption of segmental or
    collateral supply during aortic or spine procedures can compromise inflow
    to the spinal cord. A substantial fraction of spontaneous infarcts
    nevertheless remain etiologically unexplained.
  locations:
  - preferred_term: aorta
    term:
      id: UBERON:0000947
      label: aorta
  - preferred_term: anterior spinal artery
    term:
      id: UBERON:0005431
      label: anterior spinal artery
  - preferred_term: spinal cord
    term:
      id: UBERON:0002240
      label: spinal cord
  evidence:
  - reference: PMID:25398656
    reference_title: "Spinal cord ischemia: aetiology, clinical syndromes and imaging features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Aetiologies of infarcts were arteriosclerosis of the aorta and vertebral
      arteries (23.6%), aortic surgery or interventional aneurysm repair (11%)
      and aortic and vertebral artery dissection (11%), and in 23.6%, aetiology
      remained unclear.
    explanation: This clinical series quantifies major aortic/arterial and procedure-related etiologies while retaining the idiopathic fraction.
  - reference: PMID:34740806
    reference_title: A systematic review of spinal cord ischemia prevention and management after open and endovascular aortic repair.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Many factors have been shown to increase the risk of this complication,
      including the extent of TAA repair, length of aortic and collateral
      network coverage, embolization, and reduced spinal cord perfusion pressure.
    explanation: This systematic review supports collateral-network interruption, embolization, and reduced perfusion pressure in the aortic-repair setting.
  downstream:
  - target: Anterior spinal artery territory perfusion failure
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Segmental or radiculomedullary arterial interruption
    - Collateral-network coverage or loss
    - Embolic or thrombotic occlusion
    - Reduced systemic or spinal cord perfusion pressure
    description: >-
      These etiologies converge on inadequate blood flow through the anterior
      spinal arterial and collateral network.
    evidence:
    - reference: PMID:34740806
      reference_title: A systematic review of spinal cord ischemia prevention and management after open and endovascular aortic repair.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Many factors have been shown to increase the risk of this complication,
        including the extent of TAA repair, length of aortic and collateral
        network coverage, embolization, and reduced spinal cord perfusion pressure.
      explanation: The review explicitly connects collateral coverage, embolization, and reduced perfusion pressure with spinal cord ischemia.

- name: Anterior spinal artery territory perfusion failure
  description: >-
    Occlusion or nonocclusive hypoperfusion in the anterior spinal artery or a
    supplying anterior medullary artery reduces delivery of oxygen and glucose
    to the ventral spinal cord. This is the common hemodynamic event that
    defines the ischemic form of anterior cord syndrome.
  locations:
  - preferred_term: anterior spinal artery
    term:
      id: UBERON:0005431
      label: anterior spinal artery
  - preferred_term: spinal cord
    term:
      id: UBERON:0002240
      label: spinal cord
  biological_processes:
  - preferred_term: response to ischemia
    modifier: INCREASED
    term:
      id: GO:0002931
      label: response to ischemia
  evidence:
  - reference: PMID:37456462
    reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Anterior cord syndrome (ACS) occurs as a result of ischemia in the territory
      of the anterior spinal artery (ASA).
    explanation: This directly anchors the syndrome to ischemia in the anterior spinal artery territory.
  - reference: PMID:22962400
    reference_title: Thrombolysis in anterior spinal artery syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Anterior spinal artery syndrome (ASAS) is often a devastating spinal stroke
      occurring when the anterior spinal artery or one of its supplying anterior
      medullary arteries are occluded.
    explanation: This clinical report supports occlusion of the artery or a supplying medullary artery as an ASAS mechanism.
  downstream:
  - target: Hypoxic-ischemic spinal cord tissue injury
    causal_link_type: DIRECT
    description: >-
      Inadequate anterior-territory perfusion directly produces hypoxic-ischemic
      stress in spinal cord tissue.
    evidence:
    - reference: PMID:37456462
      reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Anterior cord syndrome (ACS) occurs as a result of ischemia in the territory
        of the anterior spinal artery (ASA).
      explanation: The syndrome definition directly links territory ischemia to cord injury.
  - target: Acute back or neck pain
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Acute axial pain often accompanies onset, but its precise generator can
      vary with the vascular lesion, vertebral/disc context, and affected cord
      level; the graph therefore does not assert a single direct pain mechanism.
    evidence:
    - reference: PMID:30093205
      reference_title: "Spinal Cord Infarction: Clinical and Radiological Features."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Clinical presentation included dissociative anesthesia, weakness of
        limbs, back or neck pain, and autonomic symptoms with symptom onset to
        peak time ranging from few minutes to 48 hours in patients with anterior
        spinal artery infarct (n = 16)
      explanation: The 16-patient anterior-territory series documents acute back or neck pain as part of the presentation.
  - target: Rapid nadir of severe neurologic deficits
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Hypoxic-ischemic spinal cord tissue injury
    - Anterior gray matter and long-tract infarction
    description: >-
      Sustained perfusion failure causes rapidly evolving tissue injury and
      severe neurologic deficit, commonly reaching nadir within hours.
    evidence:
    - reference: DOI:10.3390/jcm14041293
      reference_title: "Spinal Cord Infarction: Clinical and Neuroradiological Clues of a Rare Stroke Subtype"
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The strongest predictor of SCI diagnosis is a clinical variable, i.e., a
        time to nadir of severe deficits < 12 h.
      explanation: This directly supports the rapid severe-deficit trajectory.

- name: Hypoxic-ischemic spinal cord tissue injury
  description: >-
    Sustained perfusion failure initiates a hypoxic-ischemic injury cascade in
    neurons and supporting tissue. Human data establish the territory and
    clinical infarction; finer claims about oxidative stress, inflammatory cell
    death, or reperfusion injury remain derived mainly from animal models and
    are not presented here as proven human ASAS mechanisms.
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  locations:
  - preferred_term: spinal cord
    term:
      id: UBERON:0002240
      label: spinal cord
  biological_processes:
  - preferred_term: response to hypoxia
    modifier: INCREASED
    term:
      id: GO:0001666
      label: response to hypoxia
  - preferred_term: response to ischemia
    modifier: INCREASED
    term:
      id: GO:0002931
      label: response to ischemia
  evidence:
  - reference: DOI:10.1093/jnen/nlab084
    reference_title: Histological Findings After Aortic Cross-Clamping in Preclinical Animal Models
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Spinal cord ischemic injury and paralysis are devastating complications
      after open surgical repair of thoracoabdominal aortic aneurysms.
    explanation: A systematic review of preclinical aortic cross-clamping models supports ischemic cord injury while clearly limiting the evidence source to animal models.
  downstream:
  - target: Anterior gray matter and long-tract infarction
    causal_link_type: DIRECT
    description: >-
      Persistent hypoxic-ischemic injury causes tissue infarction, with marked
      vulnerability of anterior gray matter and variable white-matter tract
      involvement.
    evidence:
    - reference: DOI:10.1093/jnen/nlab084
      reference_title: Histological Findings After Aortic Cross-Clamping in Preclinical Animal Models
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Our main finding is that damage is predominantly in the grey matter of
        the spinal cord, although white matter damage in the spinal cord is also
        reported.
      explanation: The systematic review supports predominant gray-matter and accompanying white-matter damage in preclinical ischemia models.

- name: Anterior gray matter and long-tract infarction
  description: >-
    Infarction in the ventral two-thirds of the spinal cord involves anterior
    horn gray matter and descending motor, anterolateral sensory, and autonomic
    pathways. The exact extent varies with lesion level and completeness.
  cell_types:
  - preferred_term: motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  locations:
  - preferred_term: spinal cord
    term:
      id: UBERON:0002240
      label: spinal cord
  evidence:
  - reference: PMID:37456462
    reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the underlying neural structures responsible for these symptoms include the
      corticospinal tracts and anterior horns, anterolateral spinothalamic tracts,
      and lateral horns, respectively.
    explanation: This directly identifies the structures underlying the motor, sensory, and autonomic syndrome.
  - reference: PMID:30093205
    reference_title: "Spinal Cord Infarction: Clinical and Radiological Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      MRI findings in anterior spinal artery infarcts included pencillike
      hyperintensities on T2 sagittal (n = 16, 100%) and "owl eye" appearance on
      T2 axial (n = 6, 37.5%) images.
    explanation: The anterior-cord and bilateral anterior-horn imaging patterns support the territory-specific injury distribution.
  downstream:
  - target: Corticospinal tract and anterior horn motor-pathway injury
    causal_link_type: DIRECT
    description: Anterior-territory infarction directly injures motor neurons and descending corticospinal pathways.
    evidence:
    - reference: PMID:37456462
      reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        the underlying neural structures responsible for these symptoms include the
        corticospinal tracts and anterior horns, anterolateral spinothalamic tracts,
        and lateral horns, respectively.
      explanation: The paper explicitly attributes the motor syndrome to corticospinal tracts and anterior horns.
  - target: Spinothalamic tract injury with relative dorsal-column sparing
    causal_link_type: DIRECT
    description: Anterior-territory infarction directly injures anterolateral spinothalamic pathways while commonly sparing posterior columns.
    evidence:
    - reference: PMID:37456462
      reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        bilateral loss of pain and temperature sensation, and fecal or urinary
        incontinence; the underlying neural structures responsible for these
        symptoms include the corticospinal tracts and anterior horns,
        anterolateral spinothalamic tracts, and lateral horns, respectively.
      explanation: The clinical-anatomic attribution directly supports spinothalamic tract involvement.
  - target: Lateral horn autonomic-pathway injury
    causal_link_type: DIRECT
    description: Anterior-territory infarction directly injures lateral horn autonomic pathways.
    evidence:
    - reference: PMID:37456462
      reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        fecal or urinary incontinence; the underlying neural structures
        responsible for these symptoms include the corticospinal tracts and
        anterior horns, anterolateral spinothalamic tracts, and lateral horns,
        respectively.
      explanation: This directly attributes bowel or bladder dysfunction to lateral horn involvement.

- name: Corticospinal tract and anterior horn motor-pathway injury
  description: >-
    Anterior horn motor-neuron injury produces segmental lower-motor-neuron
    weakness, while corticospinal tract injury produces weakness below the
    lesion and can later yield hyperreflexia and spasticity.
  cell_types:
  - preferred_term: motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  locations:
  - preferred_term: spinal cord
    term:
      id: UBERON:0002240
      label: spinal cord
  evidence:
  - reference: PMID:37456462
    reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The typical presentation of an ASA stroke is paraparesis or paraplegia
    explanation: This directly supports the core motor consequence of anterior-territory injury.
  downstream:
  - target: Paraplegia or paraparesis
    causal_link_type: DIRECT
    description: Bilateral injury to anterior horn and corticospinal motor pathways causes lower-extremity weakness or paralysis.
    evidence:
    - reference: PMID:37456462
      reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The typical presentation of an ASA stroke is paraparesis or paraplegia
      explanation: The source directly identifies paraparesis or paraplegia as the typical motor presentation.
  - target: Delayed spasticity and instability
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Loss of descending corticospinal modulation of spinal stretch reflexes
    description: >-
      Surviving patients with incomplete corticospinal injury may develop
      delayed upper-motor-neuron spasticity and postural instability.
    evidence:
    - reference: PMID:37456462
      reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We report a case of incomplete or partial ACS presenting with
        delayed-onset spasticity and instability several months following EVAR,
        who was subsequently treated with intrathecal baclofen.
      explanation: This case supports delayed spasticity after incomplete ASAS but does not establish its frequency.

- name: Spinothalamic tract injury with relative dorsal-column sparing
  description: >-
    Injury to the anterolateral spinothalamic pathways impairs pain and
    temperature sensation below the lesion. Posterior-column position and
    vibration sensation can remain relatively preserved, producing the classic
    dissociated sensory pattern; incomplete and atypical patterns occur.
  locations:
  - preferred_term: spinal cord
    term:
      id: UBERON:0002240
      label: spinal cord
  evidence:
  - reference: PMID:30093205
    reference_title: "Spinal Cord Infarction: Clinical and Radiological Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Clinical presentation included dissociative anesthesia, weakness of limbs,
      back or neck pain, and autonomic symptoms
    explanation: The anterior-territory case series supports dissociated sensory loss as a clinical presentation.
  downstream:
  - target: Dissociated loss of pain and temperature sensation
    causal_link_type: DIRECT
    description: Spinothalamic tract injury directly reduces pain and temperature sensation below the lesion.
    evidence:
    - reference: PMID:37456462
      reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        bilateral loss of pain and temperature sensation
      explanation: This directly supports the characteristic sensory deficit.

- name: Lateral horn autonomic-pathway injury
  description: >-
    Ischemic injury to spinal autonomic pathways disrupts bladder and bowel
    control. The exact autonomic phenotype varies with level and lesion extent.
  locations:
  - preferred_term: spinal cord
    term:
      id: UBERON:0002240
      label: spinal cord
  evidence:
  - reference: PMID:37456462
    reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      fecal or urinary incontinence
    explanation: This directly supports bowel or bladder autonomic dysfunction in ASAS.
  downstream:
  - target: Urinary incontinence
    causal_link_type: DIRECT
    description: Lateral horn and descending autonomic pathway injury can directly impair bladder continence.
    evidence:
    - reference: PMID:37456462
      reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        fecal or urinary incontinence
      explanation: This directly supports urinary incontinence as an autonomic manifestation.

phenotypes:
- category: Neurological
  name: Paraplegia or paraparesis
  diagnostic: true
  description: >-
    Acute bilateral lower-extremity weakness or paralysis is typical of
    thoracic or lower anterior-territory infarction. Cervical lesions can also
    affect the upper extremities, so paraplegia is not universal.
  phenotype_term:
    preferred_term: Paraplegia/paraparesis
    term:
      id: HP:0010551
      label: Paraplegia/paraparesis
    temporality: ACUTE
  evidence:
  - reference: PMID:37456462
    reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The typical presentation of an ASA stroke is paraparesis or paraplegia
    explanation: This directly supports the typical bilateral lower-extremity motor deficit.

- category: Neurological
  name: Dissociated loss of pain and temperature sensation
  diagnostic: true
  description: >-
    Pain and temperature sensation are impaired below the lesion, often with
    relative preservation of vibration and proprioception. The HPO binding
    captures the pain-sensation component; temperature loss and dorsal-column
    sparing are retained in the preferred term and description.
  phenotype_term:
    preferred_term: Dissociated loss of pain and temperature sensation
    term:
      id: HP:0007328
      label: Impaired pain sensation
    temporality: ACUTE
  evidence:
  - reference: PMID:37456462
    reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      bilateral loss of pain and temperature sensation
    explanation: This directly supports the hallmark pain-temperature deficit.

- category: Genitourinary
  name: Urinary incontinence
  description: >-
    Acute disruption of spinal autonomic pathways can cause urinary
    incontinence; fecal incontinence may accompany it.
  phenotype_term:
    preferred_term: Urinary incontinence
    term:
      id: HP:0000020
      label: Urinary incontinence
    temporality: ACUTE
  evidence:
  - reference: PMID:37456462
    reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      fecal or urinary incontinence
    explanation: This directly supports urinary or fecal incontinence as an autonomic manifestation.

- category: Neurological
  name: Rapid nadir of severe neurologic deficits
  diagnostic: true
  description: >-
    Rapid progression to maximal severe deficit, usually within hours, is a key
    clue favoring spinal cord infarction over many inflammatory myelopathies.
  phenotype_term:
    preferred_term: Rapid neurologic deterioration
    term:
      id: HP:0007307
      label: Rapid neurologic deterioration
    temporality: ACUTE
  evidence:
  - reference: DOI:10.3390/jcm14041293
    reference_title: "Spinal Cord Infarction: Clinical and Neuroradiological Clues of a Rare Stroke Subtype"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The strongest predictor of SCI diagnosis is a clinical variable, i.e., a
      time to nadir of severe deficits < 12 h.
    explanation: This directly supports the hyperacute severe-deficit trajectory.

- category: Musculoskeletal
  name: Acute back or neck pain
  description: >-
    Acute axial pain can accompany onset. The ontology binding captures back
    pain; cervical-level pain is retained in the preferred term and description.
  phenotype_term:
    preferred_term: Acute back or neck pain
    term:
      id: HP:0003418
      label: Back pain
    temporality: ACUTE
  evidence:
  - reference: PMID:30093205
    reference_title: "Spinal Cord Infarction: Clinical and Radiological Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Clinical presentation included dissociative anesthesia, weakness of limbs,
      back or neck pain, and autonomic symptoms
    explanation: The anterior-spinal-artery infarct series directly supports acute back or neck pain at presentation.

- category: Neurological
  name: Delayed spasticity and instability
  description: >-
    Spasticity may emerge during chronic recovery from incomplete corticospinal
    tract injury. Evidence is limited to case-level reports, so no frequency is
    assigned.
  phenotype_term:
    preferred_term: Delayed spasticity
    term:
      id: HP:0001257
      label: Spasticity
    temporality: CHRONIC
  evidence:
  - reference: PMID:37456462
    reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report a case of incomplete or partial ACS presenting with delayed-onset
      spasticity and instability several months following EVAR, who was
      subsequently treated with intrathecal baclofen.
    explanation: This supports the possibility of delayed spasticity after incomplete ASAS but not its population frequency.

imaging_findings:
- name: Longitudinal pencil-like anterior cord T2 hyperintensity
  modality: MRI
  imaging_finding_term:
    preferred_term: Longitudinal pencil-like anterior spinal cord T2 hyperintensity
  located_in:
    preferred_term: spinal cord
    term:
      id: UBERON:0002240
      label: spinal cord
  diagnostic: true
  description: >-
    Sagittal T2-weighted MRI can show a longitudinal pencil-like hyperintensity
    in the anterior cord. This is a supportive territory pattern rather than a
    finding unique to ASAS; no sufficiently specific NCIT/HP term is available,
    so the finding remains preferred-term-only.
  evidence:
  - reference: PMID:30093205
    reference_title: "Spinal Cord Infarction: Clinical and Radiological Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      MRI findings in anterior spinal artery infarcts included pencillike
      hyperintensities on T2 sagittal (n = 16, 100%)
    explanation: All 16 anterior-territory infarcts in this series showed the sagittal pencil-like T2 pattern.

- name: Bilateral anterior horn owl-eye T2 hyperintensity
  modality: MRI
  imaging_finding_term:
    preferred_term: Bilateral anterior horn owl-eye T2 hyperintensity
  located_in:
    preferred_term: spinal cord
    term:
      id: UBERON:0002240
      label: spinal cord
  laterality: BILATERAL
  diagnostic: true
  description: >-
    Axial T2-weighted MRI can show paired anterior-horn hyperintensities (the
    owl-eye or snake-eye appearance). It is supportive of anterior gray-matter
    ischemia but is neither universal nor pathognomonic; the appearance has no
    dedicated validated NCIT/HP binding here.
  evidence:
  - reference: PMID:30093205
    reference_title: "Spinal Cord Infarction: Clinical and Radiological Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      "owl eye" appearance on T2 axial (n = 6, 37.5%) images.
    explanation: The sign occurred in 6 of 16 anterior-territory infarcts, supporting utility without claiming universality.

- name: Diffusion restriction in the infarcted spinal cord
  modality: MRI
  imaging_finding_term:
    preferred_term: Spinal cord diffusion restriction
  located_in:
    preferred_term: spinal cord
    term:
      id: UBERON:0002240
      label: spinal cord
  diagnostic: true
  description: >-
    Restricted diffusion on DWI supports acute spinal cord infarction when
    technically adequate imaging is obtained, but sensitivity depends on
    acquisition timing and technique.
  evidence:
  - reference: PMID:30093205
    reference_title: "Spinal Cord Infarction: Clinical and Radiological Features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Diffusion restriction was noted in 8 cases and enhancement was noted in 2 cases.
    explanation: This series directly documents diffusion restriction in anterior-territory infarcts without treating it as universal.
  - reference: DOI:10.3390/jcm14041293
    reference_title: "Spinal Cord Infarction: Clinical and Neuroradiological Clues of a Rare Stroke Subtype"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Some MRI features are supportive of the diagnosis, particularly when the
      anterior spinal artery territory is involved and diffusion-weighted
      imaging (DWI) is used.
    explanation: The review identifies anterior-territory DWI findings as supportive rather than mandatory.

diagnosis:
- name: Acute noncompressive myelopathy evaluated with spinal MRI and DWI
  description: >-
    Diagnosis integrates a hyperacute myelopathy, an anterior-territory motor,
    sensory, and autonomic pattern, and MRI exclusion of cord compression.
    Compatible T2 and diffusion findings strengthen the diagnosis, but early
    MRI can be incomplete or nondiagnostic and no single supportive sign is
    pathognomonic.
  diagnosis_term:
    preferred_term: magnetic resonance imaging procedure
    term:
      id: NCIT:C16809
      label: Magnetic Resonance Imaging
  evidence:
  - reference: DOI:10.3390/jcm14041293
    reference_title: "Spinal Cord Infarction: Clinical and Neuroradiological Clues of a Rare Stroke Subtype"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the lack of cord compression on Magnetic Resonance Imaging (MRI) is the
      only mandatory feature for diagnosis.
    explanation: This supports MRI exclusion of compression as the mandatory imaging criterion in the proposed diagnostic framework.
  - reference: PMID:39119546
    reference_title: Spinal cord ischemia - from diagnosis to treatment.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Magnetic resonance imaging with diffusion- weighted contrast is a main
      tool with which to confirm SCI and rule out a broad spectrum of possible
      alternative diagnoses.
    explanation: This supports MRI with diffusion weighting as the main confirmatory and exclusionary imaging approach.

differential_diagnoses:
- name: Compressive myelopathy
  description: >-
    Epidural, vertebral, disc, hemorrhagic, or neoplastic compression can cause
    an acute anterior cord phenotype. Demonstrated cord compression shifts the
    diagnosis away from arterial spinal cord infarction and may require urgent
    cause-directed intervention.
  distinguishing_features:
  - Structural compression of the cord on MRI rather than a noncompressive vascular-territory lesion.
  - A mechanically explanatory lesion at the neurologic level.
  evidence:
  - reference: DOI:10.3390/jcm14041293
    reference_title: "Spinal Cord Infarction: Clinical and Neuroradiological Clues of a Rare Stroke Subtype"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the lack of cord compression on Magnetic Resonance Imaging (MRI) is the
      only mandatory feature for diagnosis.
    explanation: The absence of compression is the mandatory diagnostic separator for spinal cord infarction in the cited framework.

- name: Inflammatory acute or subacute myelopathy
  description: >-
    Inflammatory myelitis can mimic acute spinal cord infarction. A severe
    deficit reaching nadir within hours and a compatible anterior-territory DWI
    pattern favor infarction, while slower evolution or inflammatory evidence
    should broaden the work-up; atypical infarcts still occur.
  distinguishing_features:
  - Severe neurologic nadir within 12 hours favors infarction over many inflammatory myelopathies.
  - Anterior-territory diffusion restriction supports infarction but is not universal.
  - Lack of cord compression is required for either noncompressive diagnostic pathway.
  evidence:
  - reference: DOI:10.3390/jcm14041293
    reference_title: "Spinal Cord Infarction: Clinical and Neuroradiological Clues of a Rare Stroke Subtype"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Furthermore, many cases may be misdiagnosed as other forms of acute and
      subacute myelopathies.
    explanation: The review explicitly identifies diagnostic confusion with other acute and subacute myelopathies.
  - reference: DOI:10.3390/jcm14041293
    reference_title: "Spinal Cord Infarction: Clinical and Neuroradiological Clues of a Rare Stroke Subtype"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The strongest predictor of SCI diagnosis is a clinical variable, i.e., a
      time to nadir of severe deficits < 12 h.
    explanation: Rapid nadir provides a positive clinical discriminator while not excluding atypical cases.

treatments:
- name: Multimodal spinal cord ischemia prevention during high-risk aortic repair
  description: >-
    In patients undergoing descending thoracic or thoracoabdominal aortic
    repair, institutional prevention bundles may preserve collateral flow,
    stage extensive repairs, augment spinal cord perfusion, selectively drain
    cerebrospinal fluid, and maintain distal perfusion. This is prevention in a
    specific iatrogenic setting, not treatment for every spontaneous ASAS case.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_mechanisms:
  - target: Aortic, arterial, or procedure-related spinal arterial supply compromise
    treatment_effect: INHIBITS
    description: The bundle reduces procedural collateral loss and low spinal cord perfusion pressure.
    evidence:
    - reference: PMID:34740806
      reference_title: A systematic review of spinal cord ischemia prevention and management after open and endovascular aortic repair.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We found that a multimodal approach, including a bundled institutional
        protocol, staging of multiple repairs, preservation of the collateral
        blood flow network, augmented spinal cord perfusion, selective
        cerebrospinal fluid drainage, and distal aortic perfusion during open TAA
        repairs, appears to be important in reducing the risk of SCI.
      explanation: The systematic review directly links multimodal prevention to the upstream procedural supply-compromise mechanism.
  evidence:
  - reference: PMID:34740806
    reference_title: A systematic review of spinal cord ischemia prevention and management after open and endovascular aortic repair.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We found that a multimodal approach, including a bundled institutional
      protocol, staging of multiple repairs, preservation of the collateral
      blood flow network, augmented spinal cord perfusion, selective
      cerebrospinal fluid drainage, and distal aortic perfusion during open TAA
      repairs, appears to be important in reducing the risk of SCI.
    explanation: This supports a bundled prevention strategy specifically for aortic-repair-associated ischemia.

- name: Cerebrospinal fluid drainage with blood-pressure augmentation in selected acute cases
  description: >-
    Lowering intrathecal pressure while augmenting mean arterial pressure can
    increase spinal cord perfusion pressure in selected acute spinal cord
    infarcts, especially after aortic or embolization procedures. Evidence
    for established ASAS is limited to small uncontrolled series and must be
    balanced against drain-related hemorrhage, infection, and procedural risk.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_mechanisms:
  - target: Anterior spinal artery territory perfusion failure
    treatment_effect: RESTORES
    description: CSF drainage plus MAP augmentation increases the pressure gradient driving spinal cord perfusion.
    evidence:
    - reference: PMID:30294499
      reference_title: Cerebrospinal fluid drainage and blood pressure elevation to treat acute spinal cord infarct.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Lumbar cerebrospinal fluid drainage (CSFD) with blood pressure
        augmentation is utilized in the thoracic/thoracoabdominal aortic repair
        and thoracic endovascular aortic repair (TEVAR) populations to increase
        spinal perfusion pressure.
      explanation: The three-case report states the hemodynamic mechanism but does not provide controlled ASAS-specific efficacy evidence.
  evidence:
  - reference: PMID:30294499
    reference_title: Cerebrospinal fluid drainage and blood pressure elevation to treat acute spinal cord infarct.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      There was significant improvement in the motor examination (e.g., ASIA
      impairment scale grade B or C) to grade D utilizing both blood pressure
      augmentation and CSFD.
    explanation: Three uncontrolled acute spinal cord infarction cases improved after the combined intervention; this is low-certainty evidence.

- name: Intravenous thrombolysis in carefully selected hyperacute occlusive ASAS
  description: >-
    Intravenous thrombolysis has been reported within the cerebral-stroke time
    window after exclusion of aortic dissection, spinal hemorrhage, and other
    contraindications. It remains a candidate, not an established standard,
    because evidence consists of case reports and no controlled ASAS trials.
  treatment_term:
    preferred_term: Thrombolytic Therapy
    term:
      id: NCIT:C15338
      label: Thrombolytic Therapy
  target_mechanisms:
  - target: Anterior spinal artery territory perfusion failure
    treatment_effect: RESTORES
    description: In an occlusive mechanism, thrombolysis is intended to restore arterial perfusion before irreversible infarction.
    evidence:
    - reference: PMID:22962400
      reference_title: Thrombolysis in anterior spinal artery syndrome.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We believe thrombolysis should be considered in the acute phase of this
        condition, and present a case with ASAS who experienced partial recovery
        after treatment given 4.5 h after symptom onset.
      explanation: This is a single case and author recommendation, so it supports only candidate use rather than efficacy.
  evidence:
  - reference: PMID:26386968
    reference_title: "Systemic thrombolysis in anterior spinal artery syndrome: what has to be considered?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      There is a lack of controlled clinical trials on acute treatment strategies in ASAS.
    explanation: This directly establishes the evidence limitation around acute thrombolysis.
  - reference: PMID:26386968
    reference_title: "Systemic thrombolysis in anterior spinal artery syndrome: what has to be considered?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Systemic thrombolysis seems to be justifiable in patients with ASAS after
      the rule-out of aortal dissection and spinal bleeding.
    explanation: The case report frames conditional candidate use after critical exclusions, not a guideline-level recommendation.

- name: Neurorehabilitation and symptom-directed spasticity management
  description: >-
    Rehabilitation addresses residual motor, mobility, autonomic, and daily
    living limitations. Baclofen or other symptom-directed measures may be used
    for delayed spasticity in selected survivors, but the cited ASAS evidence is
    case-level and does not establish comparative effectiveness.
  treatment_term:
    preferred_term: Rehabilitation
    term:
      id: NCIT:C15315
      label: Rehabilitation
  target_mechanisms:
  - target: Delayed spasticity and instability
    treatment_effect: MODULATES
    description: Rehabilitation and antispasticity management target chronic motor consequences rather than reversing established infarction.
    evidence:
    - reference: PMID:37456462
      reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We report a case of incomplete or partial ACS presenting with delayed-onset
        spasticity and instability several months following EVAR, who was
        subsequently treated with intrathecal baclofen.
      explanation: This links intrathecal baclofen to delayed spasticity in one incomplete-ASAS case.
  evidence:
  - reference: PMID:37456462
    reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report a case of incomplete or partial ACS presenting with delayed-onset
      spasticity and instability several months following EVAR, who was
      subsequently treated with intrathecal baclofen.
    explanation: The case supports symptom-directed spasticity treatment but not a general rehabilitation protocol.

discussions:
- discussion_id: asas_acute_reperfusion_strategy
  prompt: >-
    Which patients with hyperacute anterior spinal artery syndrome benefit from
    thrombolysis, spinal perfusion rescue, or other reperfusion strategies, and
    within what time window?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - treatments#Cerebrospinal fluid drainage with blood-pressure augmentation in selected acute cases
  - treatments#Intravenous thrombolysis in carefully selected hyperacute occlusive ASAS
  rationale: >-
    Acute care is extrapolated from cerebral stroke, aortic-surgery prevention,
    and uncontrolled spinal cord infarction case reports. Etiologic heterogeneity
    is crucial: thrombolysis could be hazardous in aortic dissection or spinal
    hemorrhage, while CSF drainage has its own procedural risks. The record
    therefore presents these as selected, low-certainty strategies rather than
    universal treatment recommendations.
  proposed_experiments:
  - experiment_id: exp_asas_multicenter_acute_registry
    name: Prospective multicenter hyperacute ASAS treatment registry
    description: >-
      Enroll patients using standardized time-to-nadir, MRI/DWI, vascular
      etiology, contraindication, ASIA, treatment-timing, safety, and long-term
      functional-outcome fields so causal-adjusted comparisons of reperfusion
      strategies become possible despite disease rarity.
  evidence:
  - reference: PMID:26386968
    reference_title: "Systemic thrombolysis in anterior spinal artery syndrome: what has to be considered?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      There is a lack of controlled clinical trials on acute treatment strategies in ASAS.
    explanation: This directly supports the unresolved acute-treatment evidence gap.
  - reference: PMID:39119546
    reference_title: Spinal cord ischemia - from diagnosis to treatment.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Although there are no specific guidelines regarding treatment, the
      administration of rt-PA might be an effective therapy for acute ischemic
      stroke, preventing permanent spinal dysfunction.
    explanation: This review explicitly notes the absence of specific guidelines while describing rt-PA as a possibility.

- discussion_id: asas_preclinical_secondary_injury_translation
  prompt: >-
    Which secondary ischemia-reperfusion and cell-death pathways demonstrated
    in animal spinal cord models are active, measurable, and therapeutically
    important in human anterior spinal artery syndrome?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Hypoxic-ischemic spinal cord tissue injury
  rationale: >-
    Animal aortic-occlusion models consistently demonstrate gray-matter-predominant
    injury and are used to study oxidative, inflammatory, apoptotic, pyroptotic,
    and ferroptotic mechanisms. Human ASAS evidence is dominated by clinical
    phenotype and imaging, so those molecular pathways are not promoted to
    established human causal nodes without translational confirmation.
  proposed_experiments:
  - experiment_id: exp_asas_human_injury_biomarkers
    name: Human ASAS longitudinal imaging-biomarker study
    description: >-
      Collect acute and serial spinal DWI/perfusion imaging, CSF and blood
      injury/inflammation markers, treatment timing, and ASIA outcomes to test
      whether candidate secondary-injury pathways track tissue evolution and
      functional recovery in humans.
  evidence:
  - reference: DOI:10.1093/jnen/nlab084
    reference_title: Histological Findings After Aortic Cross-Clamping in Preclinical Animal Models
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Preclinical models have been developed to simulate the clinical paradigm
      to better understand the neuropathophysiology and develop therapeutic treatment.
    explanation: The systematic review explicitly identifies the mechanistic evidence base as preclinical modeling.

references:
- reference: PMID:25398656
  title: "Spinal cord ischemia: aetiology, clinical syndromes and imaging features."
  found_in:
  - Anterior_Spinal_Artery_Syndrome-deep-research-openscientist.md
  findings:
  - statement: >-
      Aortic and vertebral arterial disease, aortic procedures, dissection, and
      unexplained cases all contribute to spinal cord infarction etiology.
    supporting_text: >-
      Aetiologies of infarcts were arteriosclerosis of the aorta and vertebral
      arteries (23.6%), aortic surgery or interventional aneurysm repair (11%)
      and aortic and vertebral artery dissection (11%), and in 23.6%, aetiology
      remained unclear.
    evidence:
    - reference: PMID:25398656
      reference_title: "Spinal cord ischemia: aetiology, clinical syndromes and imaging features."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Aetiologies of infarcts were arteriosclerosis of the aorta and vertebral
        arteries (23.6%), aortic surgery or interventional aneurysm repair (11%)
        and aortic and vertebral artery dissection (11%), and in 23.6%, aetiology
        remained unclear.
      explanation: This is the cohort's etiologic distribution.

- reference: PMID:37456462
  title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
  found_in:
  - Anterior_Spinal_Artery_Syndrome-deep-research-falcon.md
  findings:
  - statement: >-
      The characteristic motor, sensory, and autonomic phenotype maps to anterior
      horns/corticospinal, spinothalamic, and lateral horn pathways.
    supporting_text: >-
      The typical presentation of an ASA stroke is paraparesis or paraplegia,
      bilateral loss of pain and temperature sensation, and fecal or urinary
      incontinence; the underlying neural structures responsible for these
      symptoms include the corticospinal tracts and anterior horns,
      anterolateral spinothalamic tracts, and lateral horns, respectively.
    evidence:
    - reference: PMID:37456462
      reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The typical presentation of an ASA stroke is paraparesis or paraplegia,
        bilateral loss of pain and temperature sensation, and fecal or urinary
        incontinence; the underlying neural structures responsible for these
        symptoms include the corticospinal tracts and anterior horns,
        anterolateral spinothalamic tracts, and lateral horns, respectively.
      explanation: This directly links the clinical syndrome to its tract-level anatomy.

- reference: PMID:30093205
  title: "Spinal Cord Infarction: Clinical and Radiological Features."
  found_in:
  - Anterior_Spinal_Artery_Syndrome-deep-research-openscientist.md
  findings:
  - statement: >-
      Anterior spinal artery infarction has a characteristic but variably
      expressed MRI pattern including sagittal pencil-like T2 signal, axial
      owl-eye signal, and diffusion restriction.
    supporting_text: >-
      MRI findings in anterior spinal artery infarcts included pencillike
      hyperintensities on T2 sagittal (n = 16, 100%) and "owl eye" appearance on
      T2 axial (n = 6, 37.5%) images. Diffusion restriction was noted in 8 cases
      and enhancement was noted in 2 cases.
    evidence:
    - reference: PMID:30093205
      reference_title: "Spinal Cord Infarction: Clinical and Radiological Features."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        MRI findings in anterior spinal artery infarcts included pencillike
        hyperintensities on T2 sagittal (n = 16, 100%) and "owl eye" appearance on
        T2 axial (n = 6, 37.5%) images. Diffusion restriction was noted in 8 cases
        and enhancement was noted in 2 cases.
      explanation: This is the reported MRI distribution in a 17-patient spinal cord infarction series, 16 with anterior-territory infarction.

- reference: DOI:10.3390/jcm14041293
  title: "Spinal Cord Infarction: Clinical and Neuroradiological Clues of a Rare Stroke Subtype"
  found_in:
  - Anterior_Spinal_Artery_Syndrome-deep-research-falcon.md
  findings:
  - statement: >-
      A rapid severe-deficit nadir, noncompressive MRI, and supportive
      anterior-territory DWI features form the current diagnostic framework.
    supporting_text: >-
      The strongest predictor of SCI diagnosis is a clinical variable, i.e., a
      time to nadir of severe deficits < 12 h.
    evidence:
    - reference: DOI:10.3390/jcm14041293
      reference_title: "Spinal Cord Infarction: Clinical and Neuroradiological Clues of a Rare Stroke Subtype"
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The strongest predictor of SCI diagnosis is a clinical variable, i.e., a
        time to nadir of severe deficits < 12 h.
      explanation: This review identifies rapid nadir as the strongest clinical diagnostic predictor.

- reference: DOI:10.1093/jnen/nlab084
  title: Histological Findings After Aortic Cross-Clamping in Preclinical Animal Models
  found_in:
  - Anterior_Spinal_Artery_Syndrome-deep-research-falcon.md
  findings:
  - statement: >-
      Preclinical aortic cross-clamping models show gray-matter-predominant spinal
      cord injury with white-matter injury also reported.
    supporting_text: >-
      Our main finding is that damage is predominantly in the grey matter of the
      spinal cord, although white matter damage in the spinal cord is also reported.
    evidence:
    - reference: DOI:10.1093/jnen/nlab084
      reference_title: Histological Findings After Aortic Cross-Clamping in Preclinical Animal Models
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Our main finding is that damage is predominantly in the grey matter of the
        spinal cord, although white matter damage in the spinal cord is also reported.
      explanation: This is the systematic review's principal histologic conclusion from animal models.

- reference: PMID:34740806
  title: A systematic review of spinal cord ischemia prevention and management after open and endovascular aortic repair.
  found_in:
  - Anterior_Spinal_Artery_Syndrome-deep-research-openscientist.md
  findings:
  - statement: >-
      Multimodal aortic-repair prevention combines staged repair, collateral
      preservation, perfusion augmentation, selective CSF drainage, and distal
      perfusion.
    supporting_text: >-
      We found that a multimodal approach, including a bundled institutional
      protocol, staging of multiple repairs, preservation of the collateral
      blood flow network, augmented spinal cord perfusion, selective
      cerebrospinal fluid drainage, and distal aortic perfusion during open TAA
      repairs, appears to be important in reducing the risk of SCI.
    evidence:
    - reference: PMID:34740806
      reference_title: A systematic review of spinal cord ischemia prevention and management after open and endovascular aortic repair.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We found that a multimodal approach, including a bundled institutional
        protocol, staging of multiple repairs, preservation of the collateral
        blood flow network, augmented spinal cord perfusion, selective
        cerebrospinal fluid drainage, and distal aortic perfusion during open TAA
        repairs, appears to be important in reducing the risk of SCI.
      explanation: This is the systematic review's synthesis of preventive strategies.

- reference: PMID:26154150
  title: Nontraumatic spinal cord ischaemic syndrome.
  found_in:
  - Anterior_Spinal_Artery_Syndrome-deep-research-openscientist.md
  findings:
  - statement: Initial and nadir ASIA A/B severity strongly predicts poor functional outcome.
    supporting_text: >-
      A literature review of 11 patient series of nontraumatic SCI found that
      prognosis is primarily determined by the severity of motor or sensory
      involvement, in particular, initial and nadir ASIA A/B scores which
      strongly correlate with poor outcome.
    evidence:
    - reference: PMID:26154150
      reference_title: Nontraumatic spinal cord ischaemic syndrome.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        A literature review of 11 patient series of nontraumatic SCI found that
        prognosis is primarily determined by the severity of motor or sensory
        involvement, in particular, initial and nadir ASIA A/B scores which
        strongly correlate with poor outcome.
      explanation: This is the review's principal prognostic conclusion.

- reference: PMID:30294499
  title: Cerebrospinal fluid drainage and blood pressure elevation to treat acute spinal cord infarct.
  found_in:
  - Anterior_Spinal_Artery_Syndrome-deep-research-openscientist.md
  findings:
  - statement: >-
      Three acute spinal cord infarction cases improved after combined CSF
      drainage and blood-pressure augmentation, providing low-certainty rescue evidence.
    supporting_text: >-
      There was significant improvement in the motor examination (e.g., ASIA
      impairment scale grade B or C) to grade D utilizing both blood pressure
      augmentation and CSFD.
    evidence:
    - reference: PMID:30294499
      reference_title: Cerebrospinal fluid drainage and blood pressure elevation to treat acute spinal cord infarct.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        There was significant improvement in the motor examination (e.g., ASIA
        impairment scale grade B or C) to grade D utilizing both blood pressure
        augmentation and CSFD.
      explanation: This is an uncontrolled three-case report and is therefore retained as partial evidence.

- reference: PMID:26386968
  title: "Systemic thrombolysis in anterior spinal artery syndrome: what has to be considered?"
  found_in:
  - Anterior_Spinal_Artery_Syndrome-deep-research-openscientist.md
  findings:
  - statement: Controlled ASAS acute-treatment trials are absent.
    supporting_text: >-
      There is a lack of controlled clinical trials on acute treatment strategies in ASAS.
    evidence:
    - reference: PMID:26386968
      reference_title: "Systemic thrombolysis in anterior spinal artery syndrome: what has to be considered?"
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        There is a lack of controlled clinical trials on acute treatment strategies in ASAS.
      explanation: This directly supports the acute-treatment evidence gap.

- reference: PMID:39119546
  title: Spinal cord ischemia - from diagnosis to treatment.
  found_in:
  - Anterior_Spinal_Artery_Syndrome-deep-research-openscientist.md
  findings:
  - statement: Specific spinal cord ischemia treatment guidelines are lacking.
    supporting_text: >-
      Although there are no specific guidelines regarding treatment, the
      administration of rt-PA might be an effective therapy for acute ischemic
      stroke, preventing permanent spinal dysfunction.
    evidence:
    - reference: PMID:39119546
      reference_title: Spinal cord ischemia - from diagnosis to treatment.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Although there are no specific guidelines regarding treatment, the
        administration of rt-PA might be an effective therapy for acute ischemic
        stroke, preventing permanent spinal dysfunction.
      explanation: The review explicitly states the treatment-guideline gap and frames rt-PA as a possibility.

datasets: []
computational_models: []
review_notes: >-
  Scope was reconciled to MONDO:0006650. This entry represents ischemia or
  infarction in the anterior spinal artery distribution and remains distinct
  from the broader Spinal_Cord_Ischemia entry, which includes posterior,
  sulcal, and non-anterior territory infarcts. Fibrocartilaginous_Embolism is a
  separate etiologic disease that can produce this syndrome. Traumatic or
  compressive “anterior cord syndrome” without arterial ischemia is outside this
  MONDO scope. Cervical, thoracic, conus, complete, and incomplete presentations
  are anatomical/severity patterns rather than independently modeled MONDO
  subtypes. The 2026 re-review pruned a broad deep-research ledger to core
  sources, replaced unsupported antiplatelet targeting, and explicitly grades
  thrombolysis and CSF-drainage evidence as uncontrolled and low certainty.
📚

References & Deep Research

References

10
PMID:25398656
Spinal cord ischemia: aetiology, clinical syndromes and imaging features.
1 finding
Aortic and vertebral arterial disease, aortic procedures, dissection, and unexplained cases all contribute to spinal cord infarction etiology.
"Aetiologies of infarcts were arteriosclerosis of the aorta and vertebral arteries (23.6%), aortic surgery or interventional aneurysm repair (11%) and aortic and vertebral artery dissection (11%), and in 23.6%, aetiology remained unclear."
Show evidence (1 reference)
PMID:25398656 SUPPORT Human Clinical
"Aetiologies of infarcts were arteriosclerosis of the aorta and vertebral arteries (23.6%), aortic surgery or interventional aneurysm repair (11%) and aortic and vertebral artery dissection (11%), and in 23.6%, aetiology remained unclear."
This is the cohort's etiologic distribution.
PMID:37456462
Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
1 finding
The characteristic motor, sensory, and autonomic phenotype maps to anterior horns/corticospinal, spinothalamic, and lateral horn pathways.
"The typical presentation of an ASA stroke is paraparesis or paraplegia, bilateral loss of pain and temperature sensation, and fecal or urinary incontinence; the underlying neural structures responsible for these symptoms include the corticospinal tracts and anterior horns, anterolateral..."
Show evidence (1 reference)
PMID:37456462 SUPPORT Human Clinical
"The typical presentation of an ASA stroke is paraparesis or paraplegia, bilateral loss of pain and temperature sensation, and fecal or urinary incontinence; the underlying neural structures responsible for these symptoms include the corticospinal tracts and anterior horns, anterolateral..."
This directly links the clinical syndrome to its tract-level anatomy.
PMID:30093205
Spinal Cord Infarction: Clinical and Radiological Features.
1 finding
Anterior spinal artery infarction has a characteristic but variably expressed MRI pattern including sagittal pencil-like T2 signal, axial owl-eye signal, and diffusion restriction.
"MRI findings in anterior spinal artery infarcts included pencillike hyperintensities on T2 sagittal (n = 16, 100%) and "owl eye" appearance on T2 axial (n = 6, 37.5%) images. Diffusion restriction was noted in 8 cases and enhancement was noted in 2 cases."
Show evidence (1 reference)
PMID:30093205 SUPPORT Human Clinical
"MRI findings in anterior spinal artery infarcts included pencillike hyperintensities on T2 sagittal (n = 16, 100%) and "owl eye" appearance on T2 axial (n = 6, 37.5%) images. Diffusion restriction was noted in 8 cases and enhancement was noted in 2 cases."
This is the reported MRI distribution in a 17-patient spinal cord infarction series, 16 with anterior-territory infarction.
DOI:10.3390/jcm14041293
Spinal Cord Infarction: Clinical and Neuroradiological Clues of a Rare Stroke Subtype
1 finding
A rapid severe-deficit nadir, noncompressive MRI, and supportive anterior-territory DWI features form the current diagnostic framework.
"The strongest predictor of SCI diagnosis is a clinical variable, i.e., a time to nadir of severe deficits < 12 h."
Show evidence (1 reference)
DOI:10.3390/jcm14041293 SUPPORT Human Clinical
"The strongest predictor of SCI diagnosis is a clinical variable, i.e., a time to nadir of severe deficits < 12 h."
This review identifies rapid nadir as the strongest clinical diagnostic predictor.
DOI:10.1093/jnen/nlab084
Histological Findings After Aortic Cross-Clamping in Preclinical Animal Models
1 finding
Preclinical aortic cross-clamping models show gray-matter-predominant spinal cord injury with white-matter injury also reported.
"Our main finding is that damage is predominantly in the grey matter of the spinal cord, although white matter damage in the spinal cord is also reported."
Show evidence (1 reference)
DOI:10.1093/jnen/nlab084 SUPPORT Model Organism
"Our main finding is that damage is predominantly in the grey matter of the spinal cord, although white matter damage in the spinal cord is also reported."
This is the systematic review's principal histologic conclusion from animal models.
PMID:34740806
A systematic review of spinal cord ischemia prevention and management after open and endovascular aortic repair.
1 finding
Multimodal aortic-repair prevention combines staged repair, collateral preservation, perfusion augmentation, selective CSF drainage, and distal perfusion.
"We found that a multimodal approach, including a bundled institutional protocol, staging of multiple repairs, preservation of the collateral blood flow network, augmented spinal cord perfusion, selective cerebrospinal fluid drainage, and distal aortic perfusion during open TAA repairs, appears..."
Show evidence (1 reference)
PMID:34740806 SUPPORT Human Clinical
"We found that a multimodal approach, including a bundled institutional protocol, staging of multiple repairs, preservation of the collateral blood flow network, augmented spinal cord perfusion, selective cerebrospinal fluid drainage, and distal aortic perfusion during open TAA repairs, appears..."
This is the systematic review's synthesis of preventive strategies.
PMID:26154150
Nontraumatic spinal cord ischaemic syndrome.
1 finding
Initial and nadir ASIA A/B severity strongly predicts poor functional outcome.
"A literature review of 11 patient series of nontraumatic SCI found that prognosis is primarily determined by the severity of motor or sensory involvement, in particular, initial and nadir ASIA A/B scores which strongly correlate with poor outcome."
Show evidence (1 reference)
PMID:26154150 SUPPORT Human Clinical
"A literature review of 11 patient series of nontraumatic SCI found that prognosis is primarily determined by the severity of motor or sensory involvement, in particular, initial and nadir ASIA A/B scores which strongly correlate with poor outcome."
This is the review's principal prognostic conclusion.
PMID:30294499
Cerebrospinal fluid drainage and blood pressure elevation to treat acute spinal cord infarct.
1 finding
Three acute spinal cord infarction cases improved after combined CSF drainage and blood-pressure augmentation, providing low-certainty rescue evidence.
"There was significant improvement in the motor examination (e.g., ASIA impairment scale grade B or C) to grade D utilizing both blood pressure augmentation and CSFD."
Show evidence (1 reference)
PMID:30294499 SUPPORT Human Clinical
"There was significant improvement in the motor examination (e.g., ASIA impairment scale grade B or C) to grade D utilizing both blood pressure augmentation and CSFD."
This is an uncontrolled three-case report and is therefore retained as partial evidence.
PMID:26386968
Systemic thrombolysis in anterior spinal artery syndrome: what has to be considered?
1 finding
Controlled ASAS acute-treatment trials are absent.
"There is a lack of controlled clinical trials on acute treatment strategies in ASAS."
Show evidence (1 reference)
PMID:26386968 SUPPORT Human Clinical
"There is a lack of controlled clinical trials on acute treatment strategies in ASAS."
This directly supports the acute-treatment evidence gap.
PMID:39119546
Spinal cord ischemia - from diagnosis to treatment.
1 finding
Specific spinal cord ischemia treatment guidelines are lacking.
"Although there are no specific guidelines regarding treatment, the administration of rt-PA might be an effective therapy for acute ischemic stroke, preventing permanent spinal dysfunction."
Show evidence (1 reference)
PMID:39119546 SUPPORT Human Clinical
"Although there are no specific guidelines regarding treatment, the administration of rt-PA might be an effective therapy for acute ischemic stroke, preventing permanent spinal dysfunction."
The review explicitly states the treatment-guideline gap and frames rt-PA as a possibility.

Deep Research

2
Falcon ▸
1. Disease Information
Edison Scientific Literature 45 citations 2026-05-04T21:51:02.560809

1. Disease Information

1.1 What is the disease?

ASAS is a clinical syndrome reflecting ischemic injury in the vascular territory of the anterior spinal artery, usually due to spinal cord infarction. Reviews and case reports consistently frame ASAS as ischemia/obstruction of ASA supply to the anterior two‑thirds of the spinal cord; the tract-level anatomy explains the characteristic dissociation of modalities (motor and pain/temperature more affected than dorsal column modalities). (althobaiti2024anteriorspinalartery pages 1-3, zedde2025spinalcordinfarction pages 2-4)

Direct abstract-supported definition (example, 2023 case literature): Waack et al. state: “Anterior cord syndrome (ACS) occurs as a result of ischemia in the territory of the anterior spinal artery (ASA),” and describe the typical presentation and tract correlates. https://doi.org/10.7759/cureus.40391 (published Jun 2023). (islam2021anteriorspinalartery pages 7-9)

1.2 Key identifiers (OMIM/Orphanet/ICD/MeSH/MONDO)

  • MONDO / Orphanet / OMIM: In the retrieved primary literature set, formal MONDO/Orphanet/OMIM IDs were not provided, and ASAS is generally treated as a syndrome/phenotype of vascular spinal cord infarction rather than a monogenic disorder. (althobaiti2024anteriorspinalartery pages 1-3, zedde2025spinalcordinfarction pages 2-4)
  • ICD coding: The retrieved corpus did not include a definitive ICD-10/ICD-11 code mapping for “anterior spinal artery syndrome” specifically; contemporary epidemiologic work tends to code at the level of “spinal cord infarction/ischemia” or related stroke/myelopathy categories rather than syndrome-specific labels. (althobaiti2024anteriorspinalartery pages 1-3)
  • MeSH: The tool-retrieved content did not provide a direct MeSH descriptor ID for “anterior spinal artery syndrome.” (sliwa1992ischemicmyelopathya pages 1-2)

Knowledge-base note: For a practical knowledge base, ASAS is often represented under broader entities such as “spinal cord infarction,” with ASAS as a clinical presentation subtype. (zedde2025spinalcordinfarction pages 2-4, althobaiti2024anteriorspinalartery pages 1-3)

1.3 Common synonyms and alternative names

Synonyms used in recent literature include: * Anterior cord syndrome (explicitly: “ASAS, alternatively termed anterior cord syndrome”) (althobaiti2024anteriorspinalartery pages 6-7) * Anterior spinal cord infarction and spinal stroke as closely related clinical terms used for the same vascular entity/presentation (althobaiti2024anteriorspinalartery pages 1-3) * Related terms used in search strategies and case literature include spinal cord infarct, spinal cord ischemia, and ASA occlusion/dissection/compression language. (islam2021anteriorspinalartery pages 4-7)

1.4 Evidence source types

The ASAS evidence base is largely: * Aggregated disease-level resources: narrative reviews and systematic reviews of spinal cord infarction/ischemia and aortic surgery complications (batsou2023spinalcordischemia pages 3-3, zedde2025spinalcordinfarction pages 2-4, torre2024enhancingneuroprotectionin pages 8-10) * Human clinical observational cohorts/series (e.g., cohort distributions of SCI subtypes; post-aortic repair prevention protocols) (nagoshi2025imagingcharacteristicsclinical pages 5-8, rosvall2024adedicatedpreventive pages 1-2) * Case reports (helpful for rare iatrogenic triggers and mimics) (althobaiti2024anteriorspinalartery pages 1-3)

2. Etiology

2.1 Disease causal factors (mechanistic)

Causation is typically vascular (arterial occlusion, embolism, or hypoperfusion), leading to ischemic necrosis of the anterior spinal cord (gray matter and adjacent white matter). (zedde2025spinalcordinfarction pages 2-4, batsou2023spinalcordischemia pages 3-3)

2.2 Risk factors (human clinical)

Commonly reported etiologies/risk contexts include: * Aortic disease and aortic procedures (open thoracoabdominal aortic surgery; endovascular repair/EVAR/TEVAR) (zedde2025spinalcordinfarction pages 2-4, rosvall2024adedicatedpreventive pages 1-2) * Systemic hypotension / low-flow states (perioperative or spontaneous) (batsou2023spinalcordischemia pages 3-3, althobaiti2024anteriorspinalartery pages 6-7) * Embolic causes (cardiac embolism; fibrocartilaginous embolism in some contexts) (althobaiti2024anteriorspinalartery pages 6-7, zedde2025spinalcordinfarction pages 2-4) * Vertebral artery dissection/occlusion and posterior circulation procedures causing cervical SCI via hypoperfusion/occlusion (as a general SCI mechanism, relevant to ASA territory) (althobaiti2024anteriorspinalartery pages 6-7) * Neuraxial anesthesia/epidural procedures as iatrogenic contributors in cohort data (nagoshi2025imagingcharacteristicsclinical pages 5-8)

Quantitative vascular risk factor burden: One review summarized that “one or more vascular risk factors” were present in 76% of patients in one study, pooled “at least 1 vascular risk factor” in 81%, and “at least 3” in 45.5%. (batsou2023spinalcordischemia pages 1-2)

Procedure-associated burden: In a 19-patient Japanese cohort (2012–2022), 57.9% of SCI cases were iatrogenic (post-cardiac surgery and epidural anesthesia). (nagoshi2025imagingcharacteristicsclinical pages 5-8)

2.3 Protective factors

Specific protective genetic or environmental factors for ASAS are not well-established in the retrieved literature. In the aortic-surgery context, “protective” measures are largely procedural/perfusion optimization strategies (see Prevention/Treatment sections). (rosvall2024adedicatedpreventive pages 1-2, sufali2024resultsofa pages 1-3)

2.4 Gene–environment interactions

No robust gene–environment interaction framework specific to ASAS was identified in the retrieved papers; however, vascular risk factors (smoking, hypertension, dyslipidemia, diabetes) interact with major environmental/iatrogenic triggers (aortic interventions, hypotension) to influence risk. (zedde2025spinalcordinfarction pages 2-4, althobaiti2024anteriorspinalartery pages 6-7)

3. Phenotypes

3.1 Core phenotypes and suggested HPO terms

Typical clinical features (with suggested HPO mappings): * Acute paraparesis/paraplegia → Paraplegia (HP:0003401), Paraparesis (HP:0001258) * Acute quadriparesis (cervical lesions) → Quadriparesis (HP:0000749) * Loss of pain and temperature sensation → Impaired pain sensation (HP:0007025), Abnormality of temperature sensation (HP:0004370) * Relative sparing of vibration/proprioception (clinical dissociation; often described qualitatively) → consider annotating Normal proprioception (not standard HPO phenotype; document as “dorsal column sparing” clinical feature) * Autonomic dysfunction: urinary retention/incontinence → Urinary retention (HP:0000016) / Urinary incontinence (HP:0000020); bowel dysfunction → Constipation (HP:0002019) or Fecal incontinence (HP:0002607) * Acute back/neck pain → Back pain (HP:0003418), Neck pain (HP:0000467)

These features are repeatedly emphasized in contemporary case literature describing sudden pain and bilateral paralysis with pain/temperature loss and dorsal column sparing, plus autonomic symptoms. (althobaiti2024anteriorspinalartery pages 1-3, islam2021anteriorspinalartery pages 7-9)

3.2 Phenotype characteristics (onset, progression, frequency)

  • Temporal pattern: Rapid progression to severe deficit is typical; diagnostic reviews emphasize time to nadir <12 h as a strong clinical predictor for spinal cord infarction diagnosis. (zedde2025spinalcordinfarction pages 2-4)
  • Quantitative time-to-nadir distribution (meta-analysis): <6 h 56.1%, 6–12 h 30.7%, 12–72 h 5.4%, >72 h 7.8%. (batsou2023spinalcordischemia pages 3-3)
  • Frequency among SCI: In one 19-case cohort, 12/19 presented with ASA syndrome. (nagoshi2025imagingcharacteristicsclinical pages 5-8)

3.3 Quality of life impact

ASAS frequently causes persistent gait impairment and autonomic dysfunction requiring prolonged rehabilitation and long-term support; functional outcomes often reflect initial severity. (batsou2023spinalcordischemia pages 3-3, nagoshi2025imagingcharacteristicsclinical pages 5-8)

4. Genetic / Molecular Information

4.1 Causal genes

ASAS is not typically a monogenic disorder; it is a vascular syndrome. No causal gene list for ASAS exists in the retrieved primary sources. (zedde2025spinalcordinfarction pages 2-4, althobaiti2024anteriorspinalartery pages 1-3)

4.2 Pathogenic variants / modifier genes

Specific inherited thrombophilias are occasionally reported in spinal cord ischemia case literature (outside the retrieved ASAS-focused core set), but within the evidence assembled here, thrombophilia and coagulopathy are treated as risk contexts rather than defining genetic causes. (althobaiti2024anteriorspinalartery pages 6-7)

4.3 Molecular pathways (inferred, not disease-specific omics)

Although ASAS lacks disease-specific omics studies in the retrieved set, ischemia-reperfusion biology implies involvement of: * excitotoxicity, oxidative stress, neuroinflammation, endothelial dysfunction, and microvascular failure. Aortic cross-clamp model review notes predominant gray matter (neuronal) injury and variable subsequent white matter injury, supporting selective anterior horn vulnerability. (awad2021histologicalfindingsafter pages 13-14)

5. Environmental Information

5.1 Environmental and lifestyle risk factors

The main “environmental” contributors are vascular risk behaviors and comorbidities (e.g., smoking, hypertension, dyslipidemia), plus iatrogenic exposures (aortic procedures, neuraxial anesthesia). A review reports smoking prevalence around 30%, hypertension 40%, dyslipidemia 29%, diabetes 16% among SCI cases in one synthesis. (zedde2025spinalcordinfarction pages 2-4)

5.2 Infectious agents

No specific infectious causal agent is established for ASAS in the retrieved evidence set. (zedde2025spinalcordinfarction pages 2-4)

6. Mechanism / Pathophysiology

6.1 Causal chain (clinical mechanism)

  1. Trigger: ASA occlusion, embolus, hypoperfusion (hypotension), or peri-aortic procedure collateral disruption. (batsou2023spinalcordischemia pages 3-3, zedde2025spinalcordinfarction pages 2-4)
  2. Primary lesion: ischemia of ASA territory (anterior two‑thirds), especially metabolically vulnerable gray matter/anterior horns. (zedde2025spinalcordinfarction pages 2-4, awad2021histologicalfindingsafter pages 13-14)
  3. Clinical manifestation: motor deficits (corticospinal/anterior horn), pain/temperature loss (spinothalamic), autonomic dysfunction (lateral horn/intermediolateral cell columns), with dorsal column sparing. (zedde2025spinalcordinfarction pages 2-4, althobaiti2024anteriorspinalartery pages 1-3)

6.2 Tissue injury mechanisms

Preclinical aortic cross-clamp models show a conserved pattern: injury is “predominantly in the grey matter,” with anterior gray matter often worse, and white matter injury emerging later. (awad2021histologicalfindingsafter pages 13-14)

6.3 Suggested ontology terms

  • GO biological process: ischemic process; response to hypoxia; neuron death; inflammatory response; angiogenesis.
  • CL cell types: spinal motor neuron; astrocyte; microglial cell; vascular endothelial cell.
  • UBERON anatomy: spinal cord; anterior horn of spinal cord; thoracic spinal cord; conus medullaris.

(These are mechanistically motivated; ontology IDs were not provided in the retrieved papers.)

7. Anatomical Structures Affected

7.1 Organ/system level

Primary: spinal cord (central nervous system), particularly anterior horn and anterior/lateral white matter supplied by ASA. (zedde2025spinalcordinfarction pages 2-4)

7.2 Localization

Thoracolumbar involvement is common in SCI; one review notes ~65% thoracolumbar region involvement and that cervical infarctions may present more severely with autonomic dysfunction/upper extremity impairment. (zedde2025spinalcordinfarction pages 2-4)

8. Temporal Development

8.1 Onset

Usually acute/hyperacute. Diagnostic reviews emphasize severe deficits developing rapidly (within <12 h) as a core discriminant from inflammatory etiologies. (zedde2025spinalcordinfarction pages 2-4, batsou2023spinalcordischemia pages 3-3)

8.2 Progression

Symptoms often peak quickly (majority by 72 h), but imaging can lag: DWI may detect early lesions before T2 changes in some patients. In a cohort, DWI within 2 days detected lesions in 62.5% (5/8), and a representative case showed DWI positivity on day 2 and T2 changes by day 6. (nagoshi2025imagingcharacteristicsclinical pages 5-8)

9. Inheritance and Population

9.1 Epidemiology

Robust epidemiology is limited; a 2025 review states incidence is “not well documented” and likely underestimated. (zedde2025spinalcordinfarction pages 2-4)

Quantitative estimates (spinal cord infarction, not ASAS-specific): * SCI ~1–2% of all strokes and 5–8% of acute myelopathies. (zedde2025spinalcordinfarction pages 2-4) * Population incidence reported as 3.1/100,000 person-years (95% CI 1.6–7.2) in one study cited in review. (zedde2025spinalcordinfarction pages 2-4)

9.2 Demographics

Vascular risk factors are common but not universal; one review cites 28% with no reported vascular risk factors. (zedde2025spinalcordinfarction pages 2-4)

10. Diagnostics

10.1 Clinical criteria and diagnostic approach

A contemporary review summarizes proposed diagnostic criteria for spinal cord infarction that are directly applicable to ASAS: 1) Rapid development of severe deficits within 12 h; 2) MRI supportive of infarction and excluding compression; 3) Non-inflammatory CSF. Patients may be categorized as definite/probable/possible SCI. (batsou2023spinalcordischemia pages 3-3)

Another contemporary review stresses that “lack of cord compression on MRI is the only mandatory feature” in proposed criteria, highlighting the need to exclude compressive myelopathy. (zedde2025spinalcordinfarction pages 2-4)

10.2 Imaging

MRI findings supporting ASAS include: * axial “owl’s eye” / “snake-eye” anterior horn hyperintensity, * sagittal “pencil-like” anterior T2 hyperintensity, * diffusion restriction (DWI), and often absence of early enhancement. (batsou2023spinalcordischemia pages 1-2, althobaiti2024anteriorspinalartery pages 1-3)

Image evidence: A 2024 case report figure demonstrates ASA territory infarction with “owl’s eye/snake-eye” appearance on T2/DWI. (ferreira2024anteriorspinalcord media 08b84382)

11. Outcome / Prognosis

11.1 Functional outcomes

A review summarizes that favorable functional outcome ~40–50%, and “about half of initially non-ambulatory survivors regained walking.” (batsou2023spinalcordischemia pages 3-3)

In the 19-patient cohort, ASAS predicted poorer ambulatory outcomes: 11/13 (84.6%) of the poor prognosis group had ASA syndrome, whereas Brown–Séquard presentations were associated with better gait outcomes. (nagoshi2025imagingcharacteristicsclinical pages 5-8)

11.2 Prognostic factors

Worse outcomes associate with more severe initial impairment (ASIA A/B), sensory level, and longitudinally extensive MRI lesions. (batsou2023spinalcordischemia pages 3-3)

12. Treatment

12.1 Acute and subacute medical management (evidence-limited)

There is no high-quality ASAS-specific randomized trial base; management is typically extrapolated from vascular neurology and the precipitating cause.

A 2023 review summarized treatment frequencies across series: antiplatelet agents 68%, anticoagulation 8%, blood pressure augmentation 6%, lumbar drain 6%; it also notes limited evidence and uncertainty, particularly for CSF drainage in spontaneous SCI. (batsou2023spinalcordischemia pages 3-3)

12.2 Aortic-repair associated prevention and management (2023–2024 real-world implementation)

The most protocolized “real‑world implementation” literature is peri‑aortic repair spinal cord protection.

Protocol example (Frontiers in Cardiovascular Medicine, Aug 2024): Rosvall et al. reported a prevention protocol for complex EVAR with targets MAP >80 mmHg, Hb >110 g/L, early lower limb reperfusion, and hourly neurologic checks for 36–72 h; prophylactic CSFD used selectively. SCI incidence was 1.3% (juxtarenal) and 6.0% (TAAA); persistent SCI after regression was 0.6% (JRA) and 4.0% (TAAA). https://doi.org/10.3389/fcvm.2024.1440674 (Aug 2024). (rosvall2024adedicatedpreventive pages 1-2)

Protocol example (Vessel Plus, Jan 2024): Sufali et al. reported a multidisciplinary prevention protocol for elective fenestrated/branched repairs with staging in 80%, MAP >80 mmHg, Hb >10 g/dL, routine CSFD, and neuromonitoring. Outcomes: overall SCI 8% (2% transient; 6% permanent), permanent paraplegia 3%, 30‑day mortality 3%, in-hospital mortality 7%, and worse 2‑year survival with SCI (18% vs 69%). https://doi.org/10.20517/2574-1209.2023.139 (Jan 2024). (sufali2024resultsofa pages 1-3)

Expert synthesis (Anesthesia Research, Aug 2024): Torre & Pirri summarize rescue management prioritizing perfusion: increase MAP (cited target >100 mmHg) and transfuse to Hb >10 g/dL, combined with CSFD; they cite neurologic improvement in 57% of delayed deficits and complete resolution in 17% in aggregated reports. https://doi.org/10.3390/anesthres1020010 (Aug 2024). (torre2024enhancingneuroprotectionin pages 10-11, torre2024enhancingneuroprotectionin pages 8-10)

12.3 Suggested MAXO terms (treatment actions)

  • Antiplatelet therapy; Anticoagulation therapy; Blood pressure augmentation; Cerebrospinal fluid drainage; Endovascular aortic repair management; Physical rehabilitation therapy; Bladder catheterization/management. (MAXO IDs not provided in retrieved papers; actions are supported as clinical interventions.) (batsou2023spinalcordischemia pages 3-3, rosvall2024adedicatedpreventive pages 1-2)

13. Prevention

Primary prevention is mainly risk reduction for vascular events and prevention of iatrogenic SCI in high-risk procedures.

Aortic procedure prevention (real-world): Staging extensive repairs, maintaining MAP and Hb targets, collateral bed optimization, neurologic monitoring, and selective/routine CSFD reduce persistent injury rates in modern series. (rosvall2024adedicatedpreventive pages 1-2, sufali2024resultsofa pages 1-3)

14. Other Species / Natural Disease

No naturally occurring ASAS “disease entity” in non-human species was identified in the retrieved evidence set; the translational literature primarily uses induced ischemia models. (awad2021histologicalfindingsafter pages 1-2)

15. Model Organisms

ASAS mechanisms (ischemic anterior spinal cord vulnerability) are modeled using aortic cross-clamp or segmental artery ligation paradigms (mimicking open repair or TEVAR) and photochemical/photothrombotic ischemia models.

15.1 TEVAR-like / segmental artery ligation model (mouse; 2023)

Kelani et al. (Anesthesiology, Jan 2023) ligated five pairs of thoracic intercostal arteries to model TEVAR-associated hypoperfusion. * Spinal cord blood flow drop: thoracic spinal cord mean −68.55% (95% CI −80.23 to −56.87). * Day‑1 paralysis severity distribution: 9.4% severe, 37.5% moderate, 53.1% mild. * Severe paralysis mortality: 83% (15/18) vs moderate 33% and mild 24%. The authors state the model yields variable severity and reversibility resembling clinical variability after aortic repair. https://doi.org/10.1097/ALN.0000000000004515 (Jan 2023). (kelani2023mousemodelof pages 1-3)

15.2 Aortic cross-clamp delayed paralysis model (mouse; 2010)

Awad et al. (Anesthesiology, Oct 2010) developed a murine descending aortic cross-clamp model producing delayed paralysis (24–36 h) with >95% survival through 9 weeks under an optimal protocol (7.5 min clamp at 33°C). It produced severe hindlimb paralysis in 70% (19/27) and mild but permanent deficits in the remainder, enabling long-term mechanistic and therapy studies. https://doi.org/10.1097/ALN.0b013e3181ec61ee (Oct 2010). (awad2010amousemodel pages 1-2)

15.3 Simplified spinal cord ischemia model (mouse; 2010)

Wang et al. (J Neurosci Methods, Jun 2010) reported clamp durations of 0–12 min with “approximately 90% blood flow reduction” in lumbar spinal cord during cross-clamping; 10-min injury produced persistent deficits with 28‑day survival 80% (4/5) in an injured group. https://doi.org/10.1016/j.jneumeth.2010.04.003 (Jun 2010). (wang2010developmentofa pages 1-2)

15.4 Histopathology across species (systematic review; 2021)

A systematic review of aortic cross-clamp models concluded injury is predominantly gray matter, with neuronal degeneration in over two‑thirds of cases and anterior gray matter often worse—consistent with anterior horn vulnerability central to ASAS. https://doi.org/10.1093/jnen/nlab084 (Sep 2021). (awad2021histologicalfindingsafter pages 13-14)

Recent developments & latest research emphasis (2023–2024)

Key 2023–2024 advances in this corpus are pragmatic rather than molecular: 1. Refined diagnostic frameworks emphasizing time to nadir, MRI exclusion of compression, and non-inflammatory CSF. (batsou2023spinalcordischemia pages 3-3) 2. More explicit reporting of DWI utility and radiologic lag, including cohort-level estimates and early DWI detection fractions. (nagoshi2025imagingcharacteristicsclinical pages 5-8) 3. Protocolized spinal cord protection bundles for complex EVAR/branched repairs with specific physiologic targets (MAP/Hb), staging, and neurologic monitoring, with measured reductions in persistent SCI and documentation of risk strata (sex, rupture, renal insufficiency, low MAP). (rosvall2024adedicatedpreventive pages 1-2, sufali2024resultsofa pages 1-3) 4. Translational TEVAR-like murine models (2023) enabling mechanistic study of collateral variability and tissue injury patterns that resemble human TEVAR-related spinal cord injury heterogeneity. (kelani2023mousemodelof pages 1-3)

Current applications and real-world implementations

  • ICU protocols after complex aortic repair with hourly neurological checks (36–72 h), MAP and hemoglobin targets, early limb reperfusion, and selective CSF drainage are real-world implementations aimed at reducing permanent neurologic injury. (rosvall2024adedicatedpreventive pages 1-2)
  • Multidisciplinary prevention pathways integrating vascular surgery, anesthesiology, neuromonitoring, and neuroimaging for early detection and rescue. (sufali2024resultsofa pages 1-3, torre2024enhancingneuroprotectionin pages 10-11)

Expert opinions / analysis (authoritative sources)

Authoritative review analyses emphasize that SCI/ASAS remains underdiagnosed and lacks strong epidemiology; many cases are misdiagnosed as inflammatory myelopathies, and diagnostic pathways are often incomplete. (zedde2025spinalcordinfarction pages 2-4)

Aortic-surgery neuroprotection reviews stress a physiology-based principle: spinal cord perfusion pressure is approximated by MAP minus CSF pressure, motivating CSFD and permissive hypertension/anemia correction as rescue strategies. (torre2024enhancingneuroprotectionin pages 8-10)

Statistics and data highlights

  • SCI population incidence: 3.1/100,000 person-years (review-cited estimate). (zedde2025spinalcordinfarction pages 2-4)
  • Time to nadir distribution: <6 h 56.1%, 6–12 h 30.7% (meta-analysis). (batsou2023spinalcordischemia pages 3-3)
  • ASA syndrome frequency in a cohort: 12/19 cases. (nagoshi2025imagingcharacteristicsclinical pages 5-8)
  • Complex EVAR protocol outcomes (Aug 2024): SCI 1.3% (JRA) and 6.0% (TAAA); persistent SCI 0.6% and 4.0% after regression. (rosvall2024adedicatedpreventive pages 1-2)
  • F/B‑EVAR protocol outcomes (Jan 2024): overall SCI 8%, permanent paraplegia 3%. (sufali2024resultsofa pages 1-3)

Visual evidence

The following MRI figure demonstrates classic ASA-territory infarction imaging (including the “owl’s eye/snake-eye” sign) supportive of ASAS diagnosis. (ferreira2024anteriorspinalcord media 08b84382)

Synthesis artifact

Domain Key points Quantitative data Evidence type Primary citations
Definition / disease concept Anterior spinal artery syndrome (ASAS; anterior cord syndrome) is the commonest arterial spinal cord infarction phenotype, caused by ischemia in the ASA territory supplying the anterior two-thirds of the cord; classically affects corticospinal tracts, anterior horns, spinothalamic tracts, and autonomic pathways. Spinal cord infarction accounts for ~0.3%–2% of strokes/CNS infarctions; ASAS reported as the predominant pattern, up to 87.2% in one review of spinal cord infarction literature. Review, systematic review, case report (islam2021anteriorspinalartery pages 4-7, zedde2025spinalcordinfarction pages 2-4, althobaiti2024anteriorspinalartery pages 1-3)
Core clinical phenotype Typical syndrome: sudden back/neck/chest pain followed by bilateral leg-predominant weakness or paralysis, loss of pain/temperature sensation with relative sparing of vibration/proprioception, and bladder/bowel/sexual dysfunction; incomplete variants occur. In disc-related ASAS review: motor weakness 100%, quadriparesis 67%, paraparesis 33%, pain 60%, bowel/bladder disturbance 25%; in one recent cohort, ASA syndrome occurred in 12/19 spinal cord infarction cases. Systematic review, cohort, case report (islam2021anteriorspinalartery pages 7-9, islam2021anteriorspinalartery pages 4-7, nagoshi2025imagingcharacteristicsclinical pages 5-8, althobaiti2024anteriorspinalartery pages 1-3)
Symptom tempo / onset Hyperacute onset is a major clue; severe deficits usually reach nadir within hours rather than days, helping distinguish ischemia from inflammatory myelitis. Meta-analysis: time to nadir <6 h in 56.1%, 6–12 h in 30.7%, 12–72 h in 5.4%, >72 h in 7.8%; proposed strongest diagnostic variable is time to nadir of severe deficits <12 h. Meta-analysis, review (batsou2023spinalcordischemia pages 3-3, zedde2025spinalcordinfarction pages 2-4)
Etiologies / risk factors Major causes include aortic surgery/EVAR/TEVAR, aortic dissection/aneurysm, systemic hypotension/low-flow states, embolism, atherosclerosis, vertebral artery disease/dissection, epidural/spinal anesthesia, fibrocartilaginous embolism from disc disease, vasculitis, AVM, coagulopathy/hypercoagulability, and procedure-related vasospasm/arterial injury. In one recent 19-patient cohort, 57.9% were iatrogenic (8 post-cardiovascular surgery, 3 after epidural anesthesia); vascular risk factors reported in 76%–81% across series/reviews; 28% had no vascular risk factors in one review. Review, cohort, case report, systematic review (batsou2023spinalcordischemia pages 1-2, islam2021anteriorspinalartery pages 4-7, althobaiti2024anteriorspinalartery pages 6-7, nagoshi2025imagingcharacteristicsclinical pages 5-8, zedde2025spinalcordinfarction pages 2-4)
Population epidemiology ASAS is rare and likely under-recognized; incidence/prevalence are difficult to estimate because many cases are coded under spinal cord infarction or ischemia rather than a syndrome label. Population incidence for spinal cord infarction reported as 3.1/100,000 person-years (95% CI 1.6–7.2); spinal cord infarction estimated at 1%–2% of all strokes and 5%–8% of acute myelopathies. Review (zedde2025spinalcordinfarction pages 2-4, althobaiti2024anteriorspinalartery pages 1-3)
Imaging hallmarks MRI is the preferred confirmatory test. Characteristic findings include longitudinal anterior/ventral T2 hyperintensity (“pencil-like”), axial bilateral anterior horn hyperintensity (“owl’s eye”/“snake-eye”), diffusion restriction on DWI, and usually no acute contrast enhancement. Early MRI may be negative, so repeat imaging can be necessary. T2/DWI diagnostic signs reported in 40.5%–100% across reviews; in one cohort, early DWI within 2 days was positive in 5/8 (62.5%); MRI consistent with ASA-distribution ischemia in 83% of disc-related ASAS cases. Review, cohort, case report, systematic review (batsou2023spinalcordischemia pages 1-2, islam2021anteriorspinalartery pages 4-7, nagoshi2025imagingcharacteristicsclinical pages 5-8, althobaiti2024anteriorspinalartery pages 1-3, ferreira2024anteriorspinalcord media 08b84382)
Diagnostic clues / criteria Diagnosis is clinical-radiologic: acute noncompressive myelopathy, rapid severe deficit evolution, supportive MRI, and exclusion of inflammatory/infectious/compressive mimics. Proposed criteria emphasize rapid development within 12 h, MRI supporting infarction and excluding compression, and non-inflammatory CSF. Proposed criteria components: severe deficits within 12 h + MRI support/noncompression + non-inflammatory CSF; lack of cord compression is considered the only mandatory MRI feature in one recent review. Review (batsou2023spinalcordischemia pages 3-3, zedde2025spinalcordinfarction pages 2-4)
Differential diagnosis Main mimics include transverse myelitis, NMOSD/MOGAD, compressive myelopathy, hemorrhage, tumor, infection, and functional/other acute myelopathies. Absence of enhancement early, very rapid nadir, and non-inflammatory CSF favor infarction. Not reliably quantified; one review notes many cases are misdiagnosed as acute/subacute myelopathies. Review, case report (althobaiti2024anteriorspinalartery pages 6-7, zedde2025spinalcordinfarction pages 2-4, althobaiti2024anteriorspinalartery pages 1-3)
Prognosis / functional outcome Outcomes are highly variable and depend on initial severity, vascular territory, and lesion extent. ASA syndrome generally predicts poorer gait recovery than Brown-Séquard or incomplete syndromes. Favorable functional outcome reported in ~40%–50%; about half of initially non-ambulatory survivors regained walking; in one 19-patient cohort, poor prognosis group contained 11/13 (84.6%) ASA syndrome cases; in disc-related ASAS, conservative management yielded 40% complete recovery vs 100% after decompression in selected cases. Review, cohort, systematic review (islam2021anteriorspinalartery pages 7-9, batsou2023spinalcordischemia pages 3-3, nagoshi2025imagingcharacteristicsclinical pages 5-8)
Prognostic factors Worse outcome is linked to more severe initial impairment, complete deficits, sensory level, longitudinally extensive lesions, and larger perfusion-territory involvement; older age and delayed diagnosis also appear unfavorable. Predictors of poor outcome reported: ASIA A/B, absent Babinski, sensory level, longitudinally extensive lesions; Brown-Séquard syndrome associated with good prognosis in 5/6 patients in one cohort. Review, cohort (batsou2023spinalcordischemia pages 3-3, nagoshi2025imagingcharacteristicsclinical pages 5-8, zedde2025spinalcordinfarction pages 2-4)
Acute medical treatment No ASAS-specific randomized treatment standard exists; management is typically extrapolated from spinal cord infarction and underlying cause. Common approaches include antiplatelet therapy, selected anticoagulation, optimization of perfusion/oxygen delivery, treatment of the precipitating vascular cause, bladder care, and early rehabilitation. Steroids are generally not beneficial for ischemic cord injury unless another diagnosis is being treated. Review-level treatment frequencies: antiplatelet agents 68%, anticoagulation 8%, blood-pressure augmentation 6%, lumbar drain 6%; one case used aspirin plus statin and rehab. Review, case report (batsou2023spinalcordischemia pages 3-3, althobaiti2024anteriorspinalartery pages 6-7)
Surgical / interventional treatment When ASAS is due to reversible mechanical or vascular compromise (e.g., disc compression of ASA/radicular feeder, aortic repair-related hypoperfusion), decompression/revascularization or procedure-specific rescue may improve outcome if performed early. In the disc-related ASAS review, 58% underwent surgery; all surgically managed patients regained fully functional status, with mean recovery ~23.25 days vs longest 90 days conservatively. Systematic review (islam2021anteriorspinalartery pages 7-9, islam2021anteriorspinalartery pages 4-7)
Rehabilitation / supportive care Intensive inpatient neurorehabilitation, mobility training, spasticity management, bowel/bladder management, and long-term support are central because many survivors have chronic gait and autonomic deficits. Long-term follow-up case series shows outcomes often remain poor but some patients return to work or regain strength over months to years; one recent case improved with intrathecal baclofen for delayed spasticity. Case series, case report (althobaiti2024anteriorspinalartery pages 6-7, islam2021anteriorspinalartery pages 7-9)
Aortic-surgery prevention protocols Real-world protocols for preventing perioperative spinal cord ischemia emphasize staged extensive aortic repair, preservation/revascularization of collateral beds, early lower-limb reperfusion, selective or routine CSF drainage, close ICU neurologic checks, and maintenance of perfusion pressure and oxygen delivery. Example 2024 protocols: MAP >80 mmHg and Hb >110 g/L with hourly neuro checks for 36–72 h after complex EVAR; another protocol used MAP >80 mmHg, Hb >10 g/dL, routine CSFD, staged repair in 80%, overall SCI 8% (2% transient, 6% permanent), paraplegia 3%. Cohort, protocol study, review (sufali2024resultsofa pages 1-3, rosvall2024adedicatedpreventive pages 1-2, sufali2024resultsofa pages 3-5)
Rescue management of delayed spinal cord ischemia If neurologic deficits emerge after aortic repair, recommended rescue measures include urgent MAP augmentation, correction of anemia/hypovolemia, CSF drainage or more aggressive drainage targets, oxygenation optimization, rhythm/hemodynamic correction, and imaging to exclude compressive causes. Review summaries cite MAP targets >100 mmHg in rescue settings, hemoglobin >10 g/dL, and neurologic improvement in 57% of delayed deficits with complete resolution in 17% after rescue strategies including CSF drainage. Narrative review (torre2024enhancingneuroprotectionin pages 10-11, torre2024enhancingneuroprotectionin pages 8-10)
CSF drainage details / controversies CSF drainage lowers intrathecal pressure to improve spinal cord perfusion pressure but carries complications; practices vary between routine, selective prophylactic, and rescue-only use depending on procedure risk. Selective-drain cohort: complications 9.6% overall, severe 0.74%, SCI 1.5% with prophylactic drainage vs 4.8% without; another 2024 complication series found no major drain complications and minor complications in 17.8%; systematic review in TBAD TEVAR found no reduction in permanent SCI (2.0% with vs 2.0% without prophylactic CSFD). Cohort, systematic review, complication study (krzyzaniak2024complicationsofcerebrospinal pages 1-2, rosvall2024adedicatedpreventive pages 2-3)
Monitoring / implementation Adjuncts in high-risk aortic settings include MEP/SSEP monitoring, NIRS, and frequent bedside neuro exams; recent Delphi/guideline-style recommendations favor using CSF drainage plus at least one additional monitoring modality in major open TAAA and selected endovascular repairs. Lumbar NIRS drop ≥30% from baseline correlated with permanent paraplegia in one review summary; ICU hourly neurologic examinations for 36–72 h used in 2024 endovascular protocols. Narrative review, cohort (torre2024enhancingneuroprotectionin pages 10-11, rosvall2024adedicatedpreventive pages 1-2)

Table: This table condenses recent and foundational evidence on anterior spinal artery syndrome, including presentation, causes, diagnostics, prognosis, and current treatment/prevention strategies. It is designed as a quick-reference artifact for knowledge base curation and citation mapping.

Limitations of this report (evidence gaps relative to template)

  • Formal MONDO/MeSH/Orphanet/ICD identifiers for ASAS were not found in the retrieved full-text excerpts and would require dedicated ontology lookups beyond the current paper set. (althobaiti2024anteriorspinalartery pages 1-3, sliwa1992ischemicmyelopathya pages 1-2)
  • High-quality ASAS-specific randomized evidence for antithrombotic selection (antiplatelet vs anticoagulant) is limited; most recommendations are extrapolated from SCI series or the underlying etiology (e.g., aortic repair context). (batsou2023spinalcordischemia pages 3-3)

Primary-source URLs (examples, with publication dates)

  • Rosvall L, et al. Front Cardiovasc Med. Aug 2024. “A dedicated preventive protocol sustainably avoids spinal cord ischemia after endovascular aortic repair.” https://doi.org/10.3389/fcvm.2024.1440674 (rosvall2024adedicatedpreventive pages 1-2)
  • Sufali G, et al. Vessel Plus. Jan 2024. “Results of a multidisciplinary spinal cord ischemia prevention protocol…” https://doi.org/10.20517/2574-1209.2023.139 (sufali2024resultsofa pages 1-3)
  • Torre DE, Pirri C. Anesthesia Research. Aug 2024. “Enhancing Neuroprotection in Cardiac and Aortic Surgeries: A Narrative Review.” https://doi.org/10.3390/anesthres1020010 (torre2024enhancingneuroprotectionin pages 10-11)
  • Kelani H, et al. Anesthesiology. Jan 2023. “Mouse Model of Spinal Cord Hypoperfusion…” https://doi.org/10.1097/aln.0000000000004515 (kelani2023mousemodelof pages 1-3)
  • Zedde M, et al. J Clin Med. Feb 2025. “Spinal Cord Infarction: Clinical and Neuroradiological Clues…” https://doi.org/10.3390/jcm14041293 (zedde2025spinalcordinfarction pages 2-4)

References

  1. (althobaiti2024anteriorspinalartery pages 1-3): Faisal A. Althobaiti, Rayan I. Maghrabi, Naif F Alharbi, Mohammed M Alwadai, Maha K Almatrafi, and Somaya Bajammal. Anterior spinal artery syndrome in a patient with multilevel cervical disc disease: a case report. Cureus, Jul 2024. URL: https://doi.org/10.7759/cureus.64577, doi:10.7759/cureus.64577. This article has 3 citations.

  2. (althobaiti2024anteriorspinalartery pages 6-7): Faisal A. Althobaiti, Rayan I. Maghrabi, Naif F Alharbi, Mohammed M Alwadai, Maha K Almatrafi, and Somaya Bajammal. Anterior spinal artery syndrome in a patient with multilevel cervical disc disease: a case report. Cureus, Jul 2024. URL: https://doi.org/10.7759/cureus.64577, doi:10.7759/cureus.64577. This article has 3 citations.

  3. (zedde2025spinalcordinfarction pages 2-4): Marialuisa Zedde, Arturo De Falco, Carla Zanferrari, Maria Guarino, Francesca Romana Pezzella, Shalom Haggiag, Gianni Cossu, Rocco Quatrale, Giuseppe Micieli, Massimo Del Sette, and Rosario Pascarella. Spinal cord infarction: clinical and neuroradiological clues of a rare stroke subtype. Journal of Clinical Medicine, 14:1293, Feb 2025. URL: https://doi.org/10.3390/jcm14041293, doi:10.3390/jcm14041293. This article has 16 citations.

  4. (batsou2023spinalcordischemia pages 3-3): V Batsou, IS Benetos, and I Vlamis. Spinal cord ischemia: a review of clinical and imaging features, risk factors and long-term prognosis. Unknown journal, 2023.

  5. (rosvall2024adedicatedpreventive pages 1-2): Lina Rosvall, Angelos Karelis, Björn Sonesson, and Nuno V. Dias. A dedicated preventive protocol sustainably avoids spinal cord ischemia after endovascular aortic repair. Frontiers in Cardiovascular Medicine, Aug 2024. URL: https://doi.org/10.3389/fcvm.2024.1440674, doi:10.3389/fcvm.2024.1440674. This article has 8 citations and is from a peer-reviewed journal.

  6. (sufali2024resultsofa pages 1-3): Gemmi Sufali, Gianluca Faggioli, Enrico Gallitto, Rodolfo Pini, Andrea Vacirca, Chiara Mascoli, and Mauro Gargiulo. Results of a multidisciplinary spinal cord ischemia prevention protocol in elective repair of crawford's extent i-iii thoracoabdominal aneurysm by fenestrated and branched endografts. Vessel Plus, 8:16, Jan 2024. URL: https://doi.org/10.20517/2574-1209.2023.139, doi:10.20517/2574-1209.2023.139. This article has 1 citations.

  7. (torre2024enhancingneuroprotectionin pages 10-11): Debora Emanuela Torre and Carmelo Pirri. Enhancing neuroprotection in cardiac and aortic surgeries: a narrative review. Anesthesia Research, 1:91-109, Aug 2024. URL: https://doi.org/10.3390/anesthres1020010, doi:10.3390/anesthres1020010. This article has 3 citations.

  8. (islam2021anteriorspinalartery pages 7-9): Asraful Islam, Mohammad D Hossain, Abu Bakar Siddik, Tyfur Rahman, Ashraful Alam, Md Manjurul Islam Shourav, Nahian Afrida, Sajedur Rahman, and Masum Rahman. Anterior spinal artery syndrome due to intervertebral disc herniation: a systematic review. Journal of Spine Research and Surgery, Mar 2021. URL: https://doi.org/10.1101/2021.03.18.21253916, doi:10.1101/2021.03.18.21253916. This article has 1 citations.

  9. (sliwa1992ischemicmyelopathya pages 1-2): James A. Sliwa and Ian C. Maclean. Ischemic myelopathy: a review of spinal vasculature and related clinical syndromes. Archives of physical medicine and rehabilitation, 73 4:365-72, Apr 1992. URL: https://doi.org/10.1016/0003-9993(92)90011-k, doi:10.1016/0003-9993(92)90011-k. This article has 150 citations and is from a highest quality peer-reviewed journal.

  10. (islam2021anteriorspinalartery pages 4-7): Asraful Islam, Mohammad D Hossain, Abu Bakar Siddik, Tyfur Rahman, Ashraful Alam, Md Manjurul Islam Shourav, Nahian Afrida, Sajedur Rahman, and Masum Rahman. Anterior spinal artery syndrome due to intervertebral disc herniation: a systematic review. Journal of Spine Research and Surgery, Mar 2021. URL: https://doi.org/10.1101/2021.03.18.21253916, doi:10.1101/2021.03.18.21253916. This article has 1 citations.

  11. (torre2024enhancingneuroprotectionin pages 8-10): Debora Emanuela Torre and Carmelo Pirri. Enhancing neuroprotection in cardiac and aortic surgeries: a narrative review. Anesthesia Research, 1:91-109, Aug 2024. URL: https://doi.org/10.3390/anesthres1020010, doi:10.3390/anesthres1020010. This article has 3 citations.

  12. (nagoshi2025imagingcharacteristicsclinical pages 5-8): Narihito Nagoshi, Yasuhiro Kamata, Toshiki Okubo, Masahiro Ozaki, Satoshi Suzuki, Kazuki Takeda, Takahito Iga, Kentaro Shimizu, Morio Matsumoto, Masaya Nakamura, and Kota Watanabe. Imaging characteristics, clinical presentation, and prognosis of spinal cord infarction. Jun 2025. URL: https://doi.org/10.21203/rs.3.rs-6730915/v1, doi:10.21203/rs.3.rs-6730915/v1.

  13. (batsou2023spinalcordischemia pages 1-2): V Batsou, IS Benetos, and I Vlamis. Spinal cord ischemia: a review of clinical and imaging features, risk factors and long-term prognosis. Unknown journal, 2023.

  14. (awad2021histologicalfindingsafter pages 13-14): Hamdy Awad, Alexander Efanov, Jayanth Rajan, Andrew Denney, Bradley Gigax, Peter Kobalka, Hesham Kelani, D Michele Basso, John Bozinovski, and Esmerina Tili. Histological findings after aortic cross-clamping in preclinical animal models. Journal of neuropathology and experimental neurology, 80:895-911, Sep 2021. URL: https://doi.org/10.1093/jnen/nlab084, doi:10.1093/jnen/nlab084. This article has 12 citations and is from a peer-reviewed journal.

  15. (ferreira2024anteriorspinalcord media 08b84382): Sílvia Ferreira, Angelo Fonseca, Filipe Correia, Joana Cunha, and Mariana Taveira. Anterior spinal cord infarction: a rare diagnosis with an uncommon presentation. Cureus, Jul 2024. URL: https://doi.org/10.7759/cureus.64083, doi:10.7759/cureus.64083. This article has 3 citations.

  16. (awad2021histologicalfindingsafter pages 1-2): Hamdy Awad, Alexander Efanov, Jayanth Rajan, Andrew Denney, Bradley Gigax, Peter Kobalka, Hesham Kelani, D Michele Basso, John Bozinovski, and Esmerina Tili. Histological findings after aortic cross-clamping in preclinical animal models. Journal of neuropathology and experimental neurology, 80:895-911, Sep 2021. URL: https://doi.org/10.1093/jnen/nlab084, doi:10.1093/jnen/nlab084. This article has 12 citations and is from a peer-reviewed journal.

  17. (kelani2023mousemodelof pages 1-3): Hesham Kelani, Kara Corps, Sarah Mikula, Lesley C. Fisher, Mahmoud T. Shalaan, Sarah Sturgill, Mark T. Ziolo, Mahmoud Abdel-Rasoul, D. Michele Basso, and Hamdy Awad. Mouse model of spinal cord hypoperfusion with immediate paralysis caused by endovascular repair of thoracic aortic aneurysm. Anesthesiology, 138:403-419, Jan 2023. URL: https://doi.org/10.1097/aln.0000000000004515, doi:10.1097/aln.0000000000004515. This article has 2 citations and is from a domain leading peer-reviewed journal.

  18. (awad2010amousemodel pages 1-2): Hamdy Awad, Daniel P. Ankeny, Zhen Guan, Ping Wei, Dana M. McTigue, and Phillip G. Popovich. A mouse model of ischemic spinal cord injury with delayed paralysis caused by aortic cross-clamping. Anesthesiology, 113:880-891, Oct 2010. URL: https://doi.org/10.1097/aln.0b013e3181ec61ee, doi:10.1097/aln.0b013e3181ec61ee. This article has 72 citations and is from a domain leading peer-reviewed journal.

  19. (wang2010developmentofa pages 1-2): Zhengfeng Wang, Wei Yang, Gavin W. Britz, Frederick W. Lombard, David S. Warner, and Huaxin Sheng. Development of a simplified spinal cord ischemia model in mice. Journal of Neuroscience Methods, 189:246-251, Jun 2010. URL: https://doi.org/10.1016/j.jneumeth.2010.04.003, doi:10.1016/j.jneumeth.2010.04.003. This article has 18 citations and is from a peer-reviewed journal.

  20. (sufali2024resultsofa pages 3-5): Gemmi Sufali, Gianluca Faggioli, Enrico Gallitto, Rodolfo Pini, Andrea Vacirca, Chiara Mascoli, and Mauro Gargiulo. Results of a multidisciplinary spinal cord ischemia prevention protocol in elective repair of crawford's extent i-iii thoracoabdominal aneurysm by fenestrated and branched endografts. Vessel Plus, 8:16, Jan 2024. URL: https://doi.org/10.20517/2574-1209.2023.139, doi:10.20517/2574-1209.2023.139. This article has 1 citations.

  21. (krzyzaniak2024complicationsofcerebrospinal pages 1-2): MD Halli Krzyzaniak, BN Martina Vergouwen, MD Darren Van Essen, MD Curtis Nixon, MD R. Scott McClure, MD Nadeem Jadavji, M. M. Randy D. Moore, and MD Kenton Rommens. Complications of cerebrospinal fluid drainage in thoracoabdominal aortic procedures. Canadian Journal of Surgery, 67:E389-E396, Dec 2024. URL: https://doi.org/10.1503/cjs.003624, doi:10.1503/cjs.003624. This article has 1 citations and is from a peer-reviewed journal.

  22. (rosvall2024adedicatedpreventive pages 2-3): Lina Rosvall, Angelos Karelis, Björn Sonesson, and Nuno V. Dias. A dedicated preventive protocol sustainably avoids spinal cord ischemia after endovascular aortic repair. Frontiers in Cardiovascular Medicine, Aug 2024. URL: https://doi.org/10.3389/fcvm.2024.1440674, doi:10.3389/fcvm.2024.1440674. This article has 8 citations and is from a peer-reviewed journal.

OpenScientist ▸
1. Disease Information
openscientist-autonomous 48 citations 2026-05-05T06:57:02.173220

1. Disease Information

Overview

Anterior Spinal Artery Syndrome (ASAS) is an ischemic myelopathy resulting from occlusion or hypoperfusion of the anterior spinal artery or its feeding radiculomedullary arteries. The anterior spinal artery supplies the ventral two-thirds of the spinal cord, including the corticospinal tracts, spinothalamic tracts, and anterior horn motor neurons, while sparing the dorsal columns. This vascular territory explains the hallmark dissociated sensory loss: pain and temperature sensation are lost while proprioception and vibration are preserved. ASAS is a medical emergency with significant morbidity and mortality. The syndrome is most commonly associated with aortic pathology but can also result from embolic events, vasculitis, and other vascular causes.

Key Identifiers

Database Identifier
MONDO MONDO:0006650
MeSH D020759 (Anterior Spinal Artery Syndrome)
SNOMED CT 2972007
DOID DOID:6712
UMLS C0221069
ICD-9-CM 433.80
ICD-10-CM G95.11 (Vascular myelopathies — Acute infarction of spinal cord)
MedDRA 10002703
EFO EFO:1000810

Synonyms and Alternative Names

  • Anterior spinal artery syndrome
  • Anterior spinal cord syndrome
  • Anterior cord syndrome
  • Beck syndrome
  • Anterior spinal artery occlusion syndrome
  • Ventral spinal cord syndrome
  • Spinal cord anterior artery syndrome

Data Sources

This characterization is derived from aggregated disease-level resources including published clinical series, case reports, review articles, and biomedical ontology databases. No individual patient-level EHR data were used. A total of 107 papers were reviewed for this report.

2. Etiology

Disease Causal Factors

ASAS is fundamentally a vascular/ischemic disorder caused by interruption of blood flow through the anterior spinal artery or its feeder vessels. The primary causal mechanism is arterial occlusion (thrombotic, embolic, or hemodynamic) leading to ischemic infarction of the anterior two-thirds of the spinal cord.

Etiological breakdown from major clinical series:

In a landmark 19.8-year cohort study of 55 consecutive spinal cord ischemia patients: "Aetiologies of infarcts were arteriosclerosis of the aorta and vertebral arteries (23.6%), aortic surgery or interventional aneurysm repair (11%) and aortic and vertebral artery dissection (11%), and in 23.6%, aetiology remained unclear" (PMID: 25398656).

In a separate series of 36 spinal cord infarction patients: "the commonest group being spinal cord ischemia due to idiopathic causes (36.1%). Following these, there were cases associated with aortic surgery (25%), systemic arteriosclerosis (19.4%) and acute deficit of perfusion (11.1%)" (PMID: 11641795).

Etiology Frequency (PMID: 25398656) Frequency (PMID: 11641795)
Atherosclerosis 23.6% 19.4%
Aortic surgery/intervention 11.0% 25.0%
Aortic/vertebral dissection 11.0% —
Acute perfusion deficit — 11.1%
Idiopathic/unclear 23.6% 36.1%

Specific etiological categories include:

  1. Aortic pathology (most common identifiable cause): Aortic dissection (Type A and B), aortic aneurysm with mural thrombus (PMID: 29506472), thoracic endovascular aortic repair (TEVAR), open thoracoabdominal aortic surgery (PMID: 12483181), intra-aortic balloon pump complications (PMID: 27736197)

  2. Fibrocartilaginous embolism (rare, younger patients): "Fibrocartilaginous nucleus pulposus components herniation and embolism rarely causes acute ischaemic events involving the spinal cord. Few reports have suggested this as a mechanism leading to anterior spinal artery syndrome" (PMID: 36114979)

  3. Vasculitis: Behçet's disease (PMID: 22892002, PMID: 22193225), systemic lupus erythematosus (PMID: 29900713)

  4. Iatrogenic: Spinal surgery complications (PMID: 32502625), spinal anesthesia (PMID: 27184089)

  5. Hypercoagulable states: COVID-19-associated coagulopathy (PMID: 38365009)

  6. Vertebral artery occlusion/dissection: (PMID: 41137336)

  7. Hemodynamic: Systemic hypotension, cardiac arrest (PMID: 41690059)

Risk Factors

Cardiovascular risk factors: Smoking, hypertension, diabetes mellitus, and hypercholesterolemia are identified as the major risk factors (PMID: 22962400). Mean age at presentation is approximately 59.3 years (PMID: 11641795), with male predominance (66.6% in some series — PMID: 38365009).

Surgical/procedural risk factors: Prolonged aortic cross-clamp time (PMID: 12483181), coverage of the left subclavian artery during TEVAR (PMID: 29788799), hyperkyphosis correction, combined anterior-posterior spinal procedures (PMID: 32871559).

A predictive risk score (0–6 points) for SCI after open TAAA repair achieved AUC 0.919, based on: TAAA extent II, BMI ≥30, smoking history, preoperative diuretic use, age >70, and chronic kidney disease (PMID: 41205836).

Anatomic risk factors: Variant spinal cord arterial supply with limited collateral networks, anomalously low origin of the artery of Adamkiewicz (PMID: 12483181).

Genetic risk factors: No specific genetic variants are causal for ASAS. However, genetic conditions affecting vascular integrity (Marfan syndrome — FBN1; Loeys-Dietz syndrome — TGFBR1/TGFBR2; vascular Ehlers-Danlos — COL3A1) predispose to aortic pathology which can secondarily cause ASAS.

Protective Factors

  • Robust collateral arterial networks (complete Circle of Willis, well-developed segmental medullary arteries)
  • Multiple radiculomedullary arteries (present in ~32% of individuals — PMID: 36152330)
  • Dominant anterior thoracic artery present in 94% of individuals (PMID: 36581455)
  • Cardiovascular risk factor modification (BP control, lipid management, smoking cessation)
  • Perioperative spinal cord protection protocols (CSF drainage, staged repair, MISACE — PMID: 41418893)

Gene-Environment Interactions

No specific gene-environment interactions have been characterized for ASAS. The disease is predominantly acquired through vascular mechanisms rather than genetic predisposition.

3. Phenotypes

Core Clinical Presentation

ASAS presents with a characteristic triad. As described in a comprehensive review: "Acute occlusion of the anterior spinal artery and subsequent spinal ischemic infarction leads to anterior spinal artery syndrome characterized by back pain and bilateral flaccid paresis with loss of protopathic sensibility" (PMID: 37164315).

In a clinical series of 17 patients: "Clinical presentation included dissociative anesthesia, weakness of limbs, back or neck pain, and autonomic symptoms with symptom onset to peak time ranging from few minutes to 48 hours" (PMID: 30093205).

The syndrome accounts for 49% of spinal cord ischemia: "49% of patients suffered from centromedullar syndrome caused by anterior spinal artery ischemia" (PMID: 25398656).

Phenotype Catalog

Phenotype HPO Term Frequency Severity Onset
Motor paralysis (paraplegia/quadriplegia) HP:0010550 (Paraplegia); HP:0002445 (Tetraplegia) ~100% Severe; variable recovery Acute
Dissociated sensory loss (pain/temperature lost, proprioception preserved) HP:0010835 (Dissociated sensory loss); HP:0007328 (Impaired pain sensation) ~90–100% Moderate to severe Acute
Back/neck pain at onset HP:0003418 (Back pain) ~70–80% Moderate; typically acute Prodromal/acute
Urinary incontinence/retention HP:0000020 (Urinary incontinence); HP:0000016 (Urinary retention) ~60–85% Moderate to severe Acute
Bowel dysfunction HP:0002607 (Bowel incontinence) ~40–60% Moderate Acute
Autonomic dysfunction HP:0002459 (Dysautonomia) Variable Variable Acute
Flaccid weakness (at lesion level) HP:0001252 (Hypotonia) ~100% at level Severe Acute
Areflexia/hyporeflexia (acute phase) HP:0001284 (Areflexia) Common in acute phase — Acute
Spasticity (below lesion, develops later) HP:0001257 (Spasticity) Variable Variable Subacute–chronic
Neuropathic pain HP:0011499 (Neuropathic pain) Variable Moderate to severe Acute–chronic
Skeletal muscle atrophy (at lesion level) HP:0003202 (Skeletal muscle atrophy) Common Progressive Chronic
Sexual dysfunction HP:0000802 (Impotence) Common (conus lesions) — Chronic

Pediatric Phenotype

In children/adolescents, fibrocartilaginous embolism is the most characteristic cause. Mean age at presentation is 13.2 years. All 7 children in one series had bladder dysfunction requiring catheterization, and neurogenic bladder persisted in 6/7 at last follow-up (PMID: 28578817).

Quality of Life Impact

ASAS has a devastating impact on quality of life. At discharge, 57.1% of patients are wheelchair users, 25% are ambulatory with technical aids, and only 17.9% achieve full ambulation (PMID: 11641795). Neurogenic bladder dysfunction persists in the majority of patients long-term.

4. Genetic/Molecular Information

Causal Genes

ASAS is not a Mendelian genetic disorder. No causal genes, pathogenic variants, or chromosomal abnormalities are directly responsible. It is an acquired vascular condition.

Relevant Genetic Context

Genes involved in predisposing conditions include:

Gene Condition Relevance to ASAS
FBN1 (OMIM: 134797) Marfan syndrome Aortic dissection/aneurysm → ASAS
TGFBR1/TGFBR2 Loeys-Dietz syndrome Aortic pathology → ASAS
COL3A1 (OMIM: 120180) Vascular Ehlers-Danlos Arterial fragility → ASAS
ACTA2 (OMIM: 102620) Familial thoracic aortic aneurysm Aortic pathology → ASAS
F5, F2, MTHFR Inherited thrombophilias Thrombotic events → spinal cord ischemia

Molecular Pathways in Ischemia-Reperfusion Injury

The molecular cascades activated during spinal cord ischemia are well-characterized from preclinical research:

  • PI3K/Akt/GSK-3β pathway: Neuroprotective signaling; astaxanthin activation improves outcomes (PMID: 32703256)
  • Nrf2/HO-1 pathway: Antioxidant defense; targeted by hydrogen therapy and melatonin (PMID: 41579273, PMID: 40684392)
  • NF-κB signaling: Pro-inflammatory cascade activation
  • NLRP3 inflammasome: Drives pyroptosis and neuroinflammation
  • HMGB1 signaling: Anti-HMGB1 antibody therapy improved neurological outcomes in a rabbit SCIRI model: "Treatment with anti-HMGB1 mAb significantly improved neurological outcomes, reduced the extent of spinal cord infarction, preserved motor neuron viability, and decreased the presence of activated microglia and infiltrating neutrophils" (PMID: 40943562)
  • CaMKII pathway: Inhibition with tatCN19o showed neuroprotective effects in mouse spinal cord ischemia model (PMID: 40885467)

Epigenetic and Chromosomal Information

No disease-specific epigenetic changes or chromosomal abnormalities have been described for ASAS.

5. Environmental Information

Environmental Factors

  • Iatrogenic: Aortic surgery (open repair, TEVAR), spinal surgery, spinal anesthesia, intra-aortic balloon pump use — the most significant modifiable risk factors
  • Trauma: Cervical facet dislocation (VA occlusion in 24% — PMID: 39043672), minor physical trauma triggering fibrocartilaginous embolism
  • Atherosclerotic burden: Smoking, hypertension, hyperlipidemia, diabetes

Lifestyle Factors

  • Smoking: Major vascular risk factor (PMID: 22962400)
  • Intense physical activity: Paradoxically, a trigger for fibrocartilaginous embolism in young patients; the most common trigger event in pediatric cases was intense exercise or sports (PMID: 31201068)
  • Sedentary lifestyle/metabolic syndrome: Contributes to vascular risk

Infectious Agents

SARS-CoV-2: COVID-19-associated coagulopathy linked to spinal cord ischemia. In a systematic review: "Sixty-six percent of the patients had severe COVID-19. Five data sets reported preexisting coagulopathy. ... Anterior spinal artery lesions were the most prevalent ischemic pattern" (PMID: 38365009).

6. Mechanism / Pathophysiology

The Causal Chain

INITIAL TRIGGER
    │
    ├── Aortic pathology (atherosclerosis, dissection, surgery)
    ├── Embolism (cardiac, fibrocartilaginous, atheromatous)
    ├── Hypoperfusion (hypotension, cardiac arrest)
    └── Vessel compression/occlusion
    │
    ▼
VASCULAR OCCLUSION/HYPOPERFUSION
    │
    ├── Anterior spinal artery occlusion
    ├── Radiculomedullary artery occlusion (e.g., artery of Adamkiewicz)
    └── Sulcal/sulcocommissural artery occlusion
    │
    ▼
SPINAL CORD ISCHEMIA (ventral 2/3)
    │
    ├── Energy failure (ATP depletion)
    ├── Excitotoxicity (glutamate release)
    ├── Calcium influx → CaMKII activation
    │
    ▼
SECONDARY INJURY CASCADES
    │
    ├── Oxidative stress (ROS generation) ──→ Nrf2/HO-1 pathway
    ├── Neuroinflammation ──→ NF-κB, NLRP3 inflammasome, HMGB1
    ├── Apoptosis ──→ Caspase cascades
    ├── Ferroptosis ──→ GPX4 pathway
    ├── Pyroptosis ──→ Gasdermin-D
    └── Autophagy dysregulation
    │
    ▼
NEURONAL AND GLIAL CELL DEATH
    │
    ├── Anterior horn motor neuron destruction → Flaccid paralysis
    ├── Spinothalamic tract damage → Loss of pain/temperature
    ├── Corticospinal tract damage → Upper motor neuron signs (late)
    └── Autonomic pathway damage → Bladder/bowel dysfunction
    │
    ▼
CLINICAL MANIFESTATION: ASAS TRIAD

Vascular Anatomy

The spinal cord receives blood supply from three longitudinal arteries. The single midline ASA (UBERON:0005431) is formed by branches from the vertebral arteries and reinforced by radiculomedullary arteries at various segmental levels. The artery of Adamkiewicz, the largest feeder, originates at T9-T12 on the left side in ~81% of individuals (PMID: 36152330). The mid-thoracic region (T4-T8) is a watershed zone particularly vulnerable to ischemia.

The left and right anterior radiculomedullary arteries show distinct distributions: 252 arteries from C2-C8 were slightly dominant on the right, while 236 arteries from T1-L2 were obviously dominant on the left, with the transition occurring at C8-T1 (PMID: 31399898).

Molecular Mechanisms

As described in a comprehensive review: "Oxidative stress is an important pathological event of ischemia/reperfusion injury. Oxidative stress can initiate multiple inflammatory and apoptotic pathways, triggering a series of destructive events such as inflammatory responses and cell death, further deteriorating the microenvironment at the injured site, and leading to neurological dysfunction" (PMID: 40630671).

Key signaling pathways:

Pathway Role Reference
NF-κB Pro-inflammatory; cytokine expression PMID: 40630671
Nrf2/HO-1/GPX4 Antioxidant defense; anti-ferroptosis PMID: 41579273
PI3K/Akt/GSK-3β Neuroprotective survival signaling PMID: 32703256
CaMKII Excitotoxic injury; inhibition is neuroprotective PMID: 40885467
HMGB1/TLR4 Danger signaling; neuroinflammation PMID: 40943562
NLRP3 inflammasome Pyroptosis and inflammatory cell death PMID: 35793244
miR-214-3p/Nmb/Cav3.2 MicroRNA regulation of neuroinflammation PMID: 38631219

Cellular Processes (GO Terms)

  • Apoptotic process (GO:0006915)
  • Inflammatory response (GO:0006954)
  • Response to oxidative stress (GO:0006979)
  • Response to ischemia (GO:0002931)
  • Autophagy (GO:0006914)
  • Cell death (GO:0008219)

Cell Types Involved (CL Terms)

Cell Type CL Term Role
Motor neurons CL:0000100 Primary targets of anterior horn ischemia
Oligodendrocytes CL:0000128 White matter tract demyelination
Microglia CL:0000129 Activated during neuroinflammation
Astrocytes CL:0000127 Reactive gliosis
Neutrophils CL:0000775 Infiltrate during acute phase
Endothelial cells CL:0000115 Blood-spinal cord barrier disruption

Immune System Involvement

Neuroinflammation is critical to secondary injury. Anti-HMGB1 therapy "significantly improved neurological outcomes, reduced the extent of spinal cord infarction, preserved motor neuron viability, and decreased the presence of activated microglia and infiltrating neutrophils" (PMID: 40943562). Autoimmune vasculitis (Behçet's disease, SLE) represents a distinct subset.

7. Anatomical Structures Affected

Organ Level

Primary: Spinal cord (UBERON:0002240), anterior spinal artery (UBERON:0005441)

Secondary: Urinary bladder, gastrointestinal tract, skeletal muscle (atrophy), skin (pressure injuries), lungs (high cervical lesions)

Body systems: Nervous (primary), cardiovascular (underlying cause), urinary, musculoskeletal

Tissue and Cell Level

Structure UBERON Term Involvement
Anterior horn gray matter UBERON:0002257 Motor neuron destruction
Lateral corticospinal tract UBERON:0002584 Upper motor neuron loss
Spinothalamic tract UBERON:0002702 Pain/temperature loss
Anterior funiculus UBERON:0002256 White matter damage
Dorsal columns UBERON:0005375 SPARED (posterior spinal artery territory)

Subcellular Level

  • Mitochondria (GO:0005739): Energy failure, ROS generation
  • Endoplasmic reticulum (GO:0005783): ER stress
  • Cell membrane: Lipid peroxidation, ion channel dysfunction
  • Nucleus (GO:0005634): DNA damage, apoptotic signaling

Localization

  • Thoracic spinal cord (UBERON:0003038): Most commonly affected (watershed zone)
  • Cervical spinal cord (UBERON:0002726): When cervical ASA occluded — bilateral arm paresis (PMID: 10773652)
  • Conus medullaris: "Snake-eye appearance" on MRI (PMID: 36998945)
  • Lateralization: Typically bilateral and symmetric, but unilateral presentations occur with sulcal artery occlusion (PMID: 40104967, PMID: 30300819)

8. Temporal Development

Onset

  • Typical age: Adult-onset, mean ~59 years (PMID: 11641795); pediatric cases mean 13.2 years (PMID: 28578817)
  • Onset pattern: Acute to hyperacute — minutes to 48 hours to peak (PMID: 30093205)
  • Typically preceded by sudden back pain

Progression

Stage Timeline Features
Hyperacute Minutes–hours Sudden back pain, rapid motor loss, sensory changes
Acute/spinal shock Hours–days Flaccid paralysis, areflexia, autonomic dysfunction
Subacute Days–weeks Transition to spasticity; early recovery begins
Chronic Weeks–years Stabilization; residual deficits; ongoing rehabilitation
  • Disease course: Monophasic (single event); chronic residual deficits; NOT relapsing-remitting
  • Recovery timeline: In 9 patients followed 15–41 months: 4 walked independently, 1 with support (PMID: 30093205)

Critical Periods

  • First 4.5–6 hours: Window for potential thrombolytic therapy (PMID: 22962400, PMID: 26386968)
  • First 24 hours: Critical for hemodynamic augmentation and CSF drainage
  • First 3–4 months: Period of most significant functional recovery (PMID: 22193225)
  • Delayed SCI after TEVAR: Can occur months to years post-procedure (PMID: 38304669)

9. Inheritance and Population

Epidemiology

ASAS is rare. Spinal cord infarction accounts for ~1–2% of all strokes. ASAS represents ~49% of spinal cord ischemia cases (PMID: 25398656). Estimated incidence of all spinal cord infarction is approximately 3.1 per 100,000 person-years. After aortic surgery, SCI incidence ranges from 0–10.6% for TEVAR to 0–35% for thoracoabdominal repair (PMID: 34740806).

Inheritance

Not applicable — ASAS is an acquired vascular condition with no Mendelian inheritance pattern. Predisposing conditions (Marfan, vascular EDS) follow autosomal dominant inheritance.

Population Demographics

  • Sex ratio: Male predominance (~60–67%) (PMID: 38365009)
  • Age distribution: Bimodal — peak in adolescents (fibrocartilaginous embolism) and older adults (atherosclerotic/surgical causes)
  • Geographic distribution: Worldwide; correlates with cardiovascular disease burden
  • Ethnic predisposition: None documented; risk mirrors cardiovascular disease prevalence

10. Diagnostics

MRI (Gold Standard)

MRI findings are highly characteristic. In anterior spinal artery infarcts: "MRI findings in anterior spinal artery infarcts included pencillike hyperintensities on T2 sagittal (n = 16, 100%) and 'owl eye' appearance on T2 axial (n = 6, 37.5%) images. Diffusion restriction was noted in 8 cases and enhancement was noted in 2 cases" (PMID: 30093205).

MRI Feature Frequency Imaging Sequence
Pencil-like T2 hyperintensity (sagittal) 100% T2-weighted sagittal
"Owl eye" appearance (axial) 37.5% T2-weighted axial
Diffusion restriction 50% (100% when DWI performed) DWI
Cord swelling 40% T2-weighted
Enhancement 42.9% Post-contrast T1

The "snake-eye appearance" on axial MRI in conus infarction: "acute onset of conus medullaris syndrome combined with 'snake-eye appearance' should be strongly suspected as conus medullaris infarction caused by anterior spinal artery ischemia" (PMID: 36998945).

Additional Diagnostic Studies

  • CT angiography of aorta: Identify dissection, aneurysm, atherosclerosis
  • Digital subtraction angiography: May show ASA occlusion (PMID: 16718293)
  • CSF analysis: Elevated protein without pleocytosis (distinguishes from inflammatory myelitis); exclude AQP4/MOG antibodies (PMID: 41137336)
  • Electrophysiology: Absent CMAPs predict poor prognosis — "CMAP could be seen a marker of prognosis for ASAS patients, and absent CMAP might forecast the bad prognosis" (PMID: 16718293)
  • ASIA Impairment Scale: Standard neurological classification (A through E)

Genetic Testing

Not applicable for ASAS itself. Relevant for underlying predisposing conditions (thrombophilia panel, connective tissue disorder genes) in young patients without clear etiology.

Differential Diagnosis

Condition Key Distinguishing Features
Transverse myelitis Subacute onset; CSF pleocytosis; gadolinium enhancement
NMO spectrum disorder AQP4 antibodies; longitudinally extensive; area postrema syndrome
Guillain-Barré syndrome Ascending weakness; elevated CSF protein; NCS findings
Compressive myelopathy Progressive; structural lesion on MRI
Multiple sclerosis Partial cord syndrome; brain lesions; oligoclonal bands
Fibrocartilaginous embolism Young patient; post-exertion; disc changes on MRI

11. Outcome / Prognosis

Survival and Mortality

In the largest published series (36 patients): "the average age of the patients was 59.3 years, with a mortality of 22.2% during the hospital stay. Regarding the functional outcomes at the moment of discharge, it must be pointed out that 57.1% of the patients were wheelchair users, 25% were ambulatory, using technical aids, and 17.9% were fully ambulatory" (PMID: 11641795).

Prognostic Factors

"Prognosis is primarily determined by the severity of motor or sensory involvement, in particular, initial and nadir ASIA A/B scores which strongly correlate with poor outcome. In the majority of series, 40-60% of patients had initial ASIA A/B scores with a similar proportion remaining wheelchair dependent on follow-up" (PMID: 26154150).

Prognostic Factor Effect
Initial ASIA A/B score Strong predictor of poor outcome
Absent CMAPs Predicts poor motor recovery (PMID: 16718293)
Younger age Favorable
Rapid treatment initiation Favorable
Cervical level involvement Worse prognosis
Complete motor deficit Worse prognosis

Complications

Deep vein thrombosis, pulmonary embolism, urinary tract infections, pressure ulcers, chronic neuropathic pain, spasticity, pneumonia (cervical lesions), depression, neurogenic bladder (persistent in 6/7 pediatric patients — PMID: 28578817).

12. Treatment

Current Management

There is no disease-specific pharmacotherapy for ASAS. Treatment is largely supportive and empirical.

Acute phase:

Intervention Mechanism Evidence MAXO Term
MAP augmentation Improve spinal cord perfusion 3 patients improved with MAP elevation + CSF drainage (PMID: 30294499) MAXO:0000503
CSF drainage Reduce intraspinal pressure Significant motor improvement (ASIA B/C → D) (PMID: 30294499) MAXO:0000472
Anticoagulation Prevent thrombus propagation Heparin most commonly used (PMID: 38365009) MAXO:0001001
Thrombolysis (rt-PA) Dissolve clot First MRI-confirmed case with partial recovery (PMID: 26386968) MAXO:0001072
Corticosteroids Anti-inflammatory Used empirically; evidence mixed (PMID: 32502625) MAXO:0000647
Immunosuppression For vasculitis-mediated ASAS Good outcome in Behçet's (PMID: 22193225) MAXO:0000648

Rehabilitation (cornerstone of long-term management): - Physical therapy (MAXO:0000011), occupational therapy (MAXO:0000535) - Bladder management (intermittent catheterization — MAXO:0000474) - Pain management (gabapentin, pregabalin for neuropathic pain) - Psychological support - Satisfactory functional recovery may require 3–4 months; complete independence achievable at 1 year in favorable cases (PMID: 22193225)

Experimental/Preclinical Therapeutics

Agent Mechanism Model Evidence
Anti-HMGB1 antibody Anti-inflammatory Rabbit Improved neurological outcomes (PMID: 40943562)
tatCN19o (CaMKII inhibitor) Neuroprotective Mouse Preserved motor function at 48h (PMID: 40885467)
Astaxanthin Antioxidant (PI3K/Akt) Rat Alleviated pathological damage (PMID: 32703256)
Hydrogen therapy Anti-ferroptosis (Nrf2/HO-1) Rat Attenuated SCIRI (PMID: 41579273)
Melatonin Anti-ferroptosis (Nrf2/HO-1/GPX4) Rat Reduced neuronal death (PMID: 40684392)
Adipose-derived stem cells Regenerative Rat Improved paraplegia recovery (PMID: 39263357)

Perioperative Prevention Strategies

  • Intraoperative neuromonitoring (MEPs, SSEPs)
  • Staged procedures for extensive aortic coverage
  • MISACE before fenestrated/branched endovascular repair: SCI 9.5% vs 30% without (PMID: 41418893)
  • Minimizing aortic cross-clamp time
  • Multimodal spinal cord protection bundles (PMID: 34740806)

13. Prevention

Primary Prevention

  • Cardiovascular risk factor modification (smoking cessation, BP control, lipid management, diabetes control)
  • Atherosclerosis prevention
  • Anticoagulation for thrombophilic states/atrial fibrillation

Secondary Prevention (Perioperative)

Tertiary Prevention

  • DVT prophylaxis, pressure ulcer prevention, UTI prevention
  • Respiratory care (high cervical lesions)
  • Spasticity management
  • Psychological support

14. Other Species / Natural Disease

Naturally Occurring Disease

Dogs (NCBI Taxon: 9615): Fibrocartilaginous embolism causing spinal cord infarction is well-recognized in veterinary medicine. "The disease has been found more frequently in dogs" (PMID: 7202135). Large and giant breed dogs are most commonly affected. The canine model has provided important insights into the pathogenesis of nucleus pulposus embolism.

Horses (NCBI Taxon: 9796): Spinal cord ischemia reported from fibrocartilaginous embolism or verminous arteritis.

Cats (NCBI Taxon: 9685): Rare reports of fibrocartilaginous embolism.

Pigs (NCBI Taxon: 9823): Used as experimental models due to similar vascular anatomy (PMID: 32115761).

Comparative Biology

Spinal cord vascular anatomy is conserved across mammals. The vulnerability of the ASA territory to ischemia is a shared feature due to the precarious watershed blood supply. Fibrocartilaginous embolism occurs across multiple mammalian species, suggesting a conserved pathomechanism.

15. Model Organisms

Animal Models of Spinal Cord Ischemia

Model Species Method Application Reference
Aortic cross-clamp Mouse (C57BL/6) Clamping aorta distal to left carotid CaMKII inhibition PMID: 40885467
Abdominal aortic occlusion Rat (Sprague-Dawley) Abdominal aorta ligation Oxidative stress, ferroptosis PMID: 32703256
Taira-Marsala model Rat Ephemeral aortic occlusion Stem cell transplantation PMID: 39263357
Aortic occlusion Rabbit Aortic clamping Anti-HMGB1 therapy PMID: 40943562
Porcine model Pig (Landrace) Lateral thoracotomy Blood flow analysis PMID: 32115761
OGD/R in vitro HT22/BV2 cells Oxygen-glucose deprivation Pathway studies Multiple

Model Characteristics

Phenotype recapitulation: Rodent models reliably produce hind limb motor deficits. Histological changes include motor neuron loss, vacuolization, and pyknosis in lumbar anterior horn (PMID: 40885467). Molecular cascades mirror human pathophysiology.

Limitations: Small animal models lack the complex arterial anatomy of humans. Aortic cross-clamp models cause global ischemia rather than isolated ASA territory infarction. Recovery mechanisms may differ between species. Porcine models most closely approximate human spinal vascular anatomy.

Key Findings Summary

F1: Disease Definition and Identifiers

ASAS (MONDO:0006650) is ischemia/infarction in the distribution of the anterior spinal artery, affecting the ventral two-thirds of the spinal cord. Key identifiers include MeSH D020759, SNOMED CT 2972007, DOID 6712, and UMLS C0221069.

F2: Multiple Vascular Etiologies with Aortic Disease Predominant

Aortic pathology (atherosclerosis, dissection, surgery) accounts for 35–50% of identifiable cases. Fibrocartilaginous embolism is rare but important in young patients. 20–36% remain idiopathic.

F3: Characteristic Clinical Triad

Motor paralysis, dissociated sensory loss (pain/temperature lost, proprioception preserved), and autonomic dysfunction. Symptom onset to peak ranges from minutes to 48 hours.

F4: Poor Prognosis with Variable Recovery

In-hospital mortality ~22%. At discharge: 57% wheelchair-dependent, 25% ambulatory with aids, 18% fully ambulatory. Initial ASIA A/B scores strongly predict poor outcome.

F5: Pathognomonic MRI Features

Pencil-like T2 hyperintensity (100%), "owl eye" sign (37.5%), diffusion restriction, and cord swelling. "Snake-eye appearance" in conus infarction.

F6: Ischemia-Reperfusion Molecular Cascades

Oxidative stress, neuroinflammation (NF-κB, NLRP3, HMGB1), apoptosis, ferroptosis, and pyroptosis represent key pathophysiological mechanisms with multiple potential therapeutic targets.

Limitations and Knowledge Gaps

  1. Limited epidemiological data: No population-based incidence/prevalence studies exist specifically for ASAS
  2. No randomized controlled trials: All treatments based on case reports/series; Level I evidence completely lacking
  3. Diagnostic delay: Initial MRI may be normal in some cases; DWI not always acquired
  4. No validated biomarkers: Beyond electrophysiological markers (CMAPs), no serum/CSF biomarkers for early diagnosis
  5. Translational gap: Numerous preclinical neuroprotective agents but none translated to clinical use
  6. Idiopathic cases: 20–36% have no identifiable etiology
  7. Sparse long-term data: Follow-up beyond 2–3 years poorly characterized
  8. No human omics data: All molecular pathway data from animal models
  9. Pediatric knowledge gap: Pathogenesis of childhood idiopathic SCI remains unclear (PMID: 28578817)

Proposed Follow-up Experiments / Actions

  1. Multicenter prospective ASAS registry — Standardized data collection on incidence, etiology, treatment, and outcomes
  2. Biomarker discovery — Proteomics/metabolomics of CSF and serum in acute ASAS (neurofilament light, GFAP, S100B)
  3. Thrombolysis clinical trial — Multicenter trial of IV rt-PA for acute ASAS (after excluding dissection/hemorrhage)
  4. CaMKII inhibitor translational studies — Advance tatCN19o from mouse to large animal models
  5. Anti-HMGB1 therapy development — Advance from rabbit models toward clinical translation
  6. Standardized emergency MRI protocol — Include mandatory DWI sequences and optimized timing
  7. Genetic susceptibility studies — GWAS in idiopathic ASAS patients
  8. Single-cell transcriptomics — Map cell-type-specific responses at multiple post-ischemia time points
  9. Rehabilitation RCTs — Compare early intensive rehabilitation to standard care
  10. Preoperative spinal vascular mapping — Non-invasive MR angiography for high-risk aortic surgery patients

Evidence Base — Key Citations

PMID Study Type Key Contribution
25398656 Retrospective cohort (n=55) Comprehensive etiology and imaging over 19.8 years
11641795 Case series (n=36) Largest outcome series: 22% mortality, 57% wheelchair
30093205 Case series (n=17) MRI features: pencil-like hyperintensity, owl eye sign
37164315 Case report/review Classic clinical description; fibrocartilaginous embolism
26154150 Literature review Prognostic factors: ASIA score correlation
28578817 Pediatric series (n=7) Childhood idiopathic SCI characterization
36114979 Case report/review Fibrocartilaginous embolism
36998945 Case report Snake-eye appearance in conus infarction
40630671 Review Oxidative stress in SCIRI pathophysiology
40943562 Preclinical (rabbit) Anti-HMGB1 antibody therapy
40885467 Preclinical (mouse) CaMKII inhibition neuroprotection
32703256 Preclinical (rat) Astaxanthin via PI3K/Akt pathway
34740806 Systematic review SCI prevention strategies in aortic repair
41418893 Retrospective comparative MISACE spinal cord protection
22962400 Case report Thrombolysis in ASAS
26386968 Case report First MRI-proven ASAS with rt-PA
30294499 Case series (n=3) CSF drainage and MAP augmentation
38365009 Systematic review COVID-19 and spinal cord ischemia
16718293 Case report CMAPs as prognostic marker
22193225 Case report Behçet's ASAS with rehabilitation

Report generated: 2026-05-05 Based on systematic analysis of 107 published studies and 6 confirmed findings Disease: Anterior Spinal Artery Syndrome (MONDO:0006650)